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Over 150,000 thyroidectomies are performed annually in the US, of which 25% are 
performed in older adults (over 65) (1).  Older adults pose unique challenges to surgical 
decision-making as the benefits of surgery must be weighed against surgical risks, co-existing 
comorbidities, and postoperative quality of life. While single institution studies demonstrate the 
safety of thyroidectomy in older adults, population based studies cite increased length of stay 
and complication rates (2-5). Additionally, prior studies demonstrate that older adults tend to 
undergo less surgery for thyroid cancer and have worse disease-specific survival (6, 7).  
While the dreaded, classic complication of recurrent or superior laryngeal nerve injury is 
rare, 30-40% of younger adults with intact nerve function still report clinical sequelae of 
laryngeal dysfunction such as a change in their voice or dysphagia (8-13).  It is not well 
understood why this occurs or who is at risk for developing these changes.   Even less is 
understood about the impact of thyroidectomy on voice, swallowing, and quality of life (QOL) in 
older adults, despite the likelihood that older adults are at even greater risk than the younger 
adults who suffer these sequelae. While, there are no tools to objectively measure laryngeal 
muscle mass and strength, frailty, in part a sarcopenia phenotype validated in older adults, 
might serve as a surrogate marker to predict voice and swallowing impairments following 
thyroidectomy.  
This thesis attempts to advance our understanding of the outcomes and surgical 
decision-making in older patients undergoing thyroidectomy. The first contribution of this thesis 
is to evaluate the impact of thyroidectomy on voice and swallowing in older adults using a 
prospective longitudinal cohort study. The second contribution is to assess the association 
between frailty and adverse voice and swallowing outcomes post-thyroidectomy. Identifying at-
risk older adults for these sequelae is critical for the development of prophylactic and 
therapeutic interventions to reduce surgical disability in the many older adults who undergo 
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thyroidectomy.  The final contribution of this thesis is to understand surgical decision-making 
regarding thyroidectomy in older adults utilizing a discrete-choice experiment administered to 
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CHAPTER 1. Introduction 
Over 150,000 thyroidectomies are performed annually in the United States (14). The 
main indications for a thyroidectomy include presence of a symptomatic, indeterminate or 
suspicious thyroid nodule, a goiter, Graves’ disease, or thyroid cancer (15). Approximately 25% 
of thyroidectomies are performed on older adults (age ≥ 65) (14). Thyroid nodules are present in 
70% of people by the age of 70 (16). Additionally, the incidence of thyroid cancer has doubled 
over the past couple of decades (17). Furthermore, the U.S. Census Bureau estimates a 58% 
increase in the population aged ≥ 65 years and an 85% increase in those aged ≥ 85 years by 
2035 (18). As life expectancy continues to increase it is expected that 18 million people will turn 
65 in the next 10 years (19). Thus, the number of thyroidectomies performed in older adults will 
continue to rise annually.  
 
However, there is a paucity of data regarding the impact of thyroidectomy in older adults 
and the existing literature focuses on safety and practice patterns. Although single institution 
studies demonstrate the safety of thyroidectomy in older patients citing similar complication 
rates in older and younger individuals, population based studies report higher rates of 
endocrine-specific and overall complications, in-hospital mortality, unplanned re-admission, 
costs, and longer mean length of stay (2, 3, 20-22).  Population-based studies additionally 
demonstrate that older patients with thyroid cancer are more likely to undergo less aggressive 
treatment than that recommended by the American Thyroid Association for all stages of disease 
(6, 7). The combination of limited and inconsistent data, evolution of treatment guidelines, and 
surgeon perception have all contributed to significant treatment variation in the management of 
older patients with surgical thyroid disease. Little is understood regarding methods that 
surgeons use regarding pre-operative risk assessment and subsequent surgical 
recommendations in older adults. Surgical decision-making in older adults is complex as 
surgical complication risks, anesthetic risks, co-existing co-morbidities, and decrement in quality 
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of life must be weighed against benefits of disease-specific mortality and the possibility of 
treating an aggressive cancer. 
 
Major thyroid-specific complications including hypoparathyroidism and nerve injury are 
uncommon even in older patients. Injury to the recurrent laryngeal nerve during thyroidectomy 
can occur in up to 10% of patients resulting in voice and swallowing alterations (23). Injury to 
the external branch of the superior laryngeal nerve impairs the production of high tones, and 
altering the voice’s fundamental frequency and ability to project. The larynx, which is innervated 
by the recurrent laryngeal and superior laryngeal nerves, serves multiple functions including 
control of respiration, airway protection, coordination of swallowing and phonation. However, 
despite the infrequent occurrence of nerve injury, 30-40% of younger patients (age 18-65) report 
sequelae of laryngeal dysfunction including changes in the quality of their voice or dysphagia, 
which has a significant impact on their quality of life and activities of daily living, but only 7% of 
these changes persist at 6 months after surgery (8-10, 24, 25). The impact of thyroidectomy on 
voice, swallowing, and quality of life in older adults who do not have a surgical complication is 
unknown. Additionally, it is unknown which older adults are at risk of developing these changes. 
 
Voice production requires coordination of three main components: intact myoelastic 
structures of the larynx for vocal fold vibration, adequate airflow from the respiratory system, 
and a strong resonating channel including the supraglottic  larynx, hypopharynx, nasopharynx, 
and oral cavity for projection. Deterioration of the cartilaginous and muscular structures of the 
larynx, decreased pulmonary function, impaired motor neuron function, and intrinsic vocal fold 
changes can all occur with aging and contribute to presbyphonia (26-29). The larynx also plays 
a central role in airway protection during swallowing and thus reduced bulk of vocal cords can 
contribute to aspiration. Aging can cause changes in the structure, motility, coordination, and 
sensitivity of the swallow process, known as presbyphonia (30). The prevalence of voice 
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problems in older patients has been reported to range from 6-29% (31-34). Additionally, age-
related sarcopenia of the myoelastic structures of the larynx might contribute to older patients 
being more vulnerable to the violation of surrounding musculature during a thyroidectomy. 
However, age is associated with a multi-system decline in reserve and may one more 
susceptible to the stressors of thyroidectomy.  
Frailty is a clinically recognizable state of increased vulnerability resulting from age-
associated decline in reserve and function across multiple physiologic systems and, is a unique 
domain and indicator of physiologic reserve characterized by increased vulnerability to 
unfavorable outcomes, decreased homeostatic reserves and lower resistance to stressor events 
such as surgery (35, 36). Because it is a condition marked by a decline in multiple physiologic 
systems leading to increased adverse outcomes from stressors, this construct  might be useful 
to predict patients who are more susceptible to the stress of thyroidectomy and develop voice 
and swallowing changes after this procedure. The frailty phenotype (shrinking, weakness, 
exhaustion, low physical activity, slowed walking speed) was first described in a cohort of 5,317 
community dwelling older adults (Cardiovascular Health Study, CHS (37). The composite 
measure has predictive validity for development of, among other adverse events, cardiovascular 
disease (38), venous thromboembolism (39), disability, hospitalization, and death (40).   
In 594 patients undergoing a general surgical procedure, pre-operative frailty phenotype 
was associated with an increased risk for postoperative complications, length of stay, and 
discharge to a skilled or assisted living facility (41).  There is now considerable literature 
regarding associations between frailty and adverse outcomes after other surgical procedures, 
such as kidney transplant. In patients who undergo kidney transplant, frailty is associated with 
delirium, delayed graft function, longer length of stay, early hospital readmission, lower health-
related quality of life, and mortality (42-47). Frailty phenotype has also been associated with 
including mortality and poor recovery in cardiac surgery (48, 49). Frailty as measured by a 
modified frailty index was associated with increased per-operative morbidity in common 
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ambulatory general surgery operations, including hernia, breast, thyroid or parathyroid 
surgery(50). Frailty as measured by a five-factor modified frailty index was also identified to be 
predictive of complications after thyroidectomy performed for a multinodular goiter (51). While 
numerous instrument exist to measure frailty, a frailty  phenotype has not been previously used 
to predict voice and swallowing changes after thyroidectomy. Conversely, the frailty phenotype 
demonstrated statistically significant differences between voice handicap index (VHI) scores 
between robust and frail patients when it was measured in 52 community dwelling and 21 
assisted living residents (52).  Due to the plethora of literature highlighting adverse outcomes 
after surgery in frail patients and the association between frailty and VHI scores, we 
hypothesize, that frailty phenotype predicts increased likelihood of developing post-operative 
adverse voice and swallowing outcomes that impacts patients’ quality of life.  An improved 
understanding of the biopsychosocial impact of thyroidectomy on voice and swallowing 
impairments is critical for informed consent, risk stratification, and peri-operative planning within 
a population of unique patients who may be at higher risk or may be more affected by these 
changes. 
 
In Chapter 2, we used a longitudinal, single institution prospective cohort study to assess 
the incidence of voice and swallowing impairments in older adults after thyroidectomy. We 
hypothesized that older adults have a higher prevalence of pre-operative voice and swallowing 
changes and subsequently report higher rates of impairment in voice and swallowing post-
thyroidectomy than that reported in the literature for younger adults. Additionally, we 
hypothesized that most of these impairments resolve by 6-months postoperatively.  
In Chapter 3, we investigated the association between frailty and impairments in voice 
and swallowing and evaluated risk factors associated with these changes. We hypothesized that 
older adults who are frail or pre-frail are more likely to have pre-operative voice or swallowing 
alterations and report changes in voice and swallowing compared to those who are robust. We 
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additionally hypothesized that frail or pre-frail patients who have impairments do not return back 
to baseline as quickly as those who are robust.  
In Chapters 4-5, we investigated how high-volume thyroid surgeons assessed older 
patients for surgery and how their recommendations changed based on patient age, functional 
status, and co-morbid conditions. We hypothesized that there is a lack of consistency among 
surgeons in methods used to assess an older adult’s fitness for surgery in addition to 
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Background: Despite intact recurrent laryngeal nerves, voice and swallowing complaints are 
common after thyroidectomy. While the occurrence of these changes has been established in 
younger patients, the development of these changes in older adults and the impact on their 
quality of life is unknown. Therefore, the aim of this study was to evaluate the impact of 
thyroidectomy on alterations in voice and swallowing in older adults. 
Materials & Methods: We performed an IRB-approved longitudinal prospective cohort study 
and enrolled older adults seen at a single institution between May 1, 2017 and July 31, 2020. All 
thyroid procedures were performed with intra-operative nerve monitoring by four high volume 
surgeons at a single institution. Patients with recurrent laryngeal nerve injury or loss of nerve 
signal were excluded.  Longitudinal assessments were performed utilizing validated surveys 
including the Voice Handicap Index (VHI) and the Dysphagia Handicap Index (DHI). The 
incidence and duration of development of impairments in voice and swallowing was examined 
and differences in mean survey scores were tabulated using a t-test. 
Results: Of 53 patients undergoing thyroidectomy, 67.9% had abnormal scores on the pre-
operative VHI and 77.4% had abnormal scores on the DHI. After thyroidectomy, 49.1% of 
patients reported worse voice in the early post-operative period and this persisted in 32% of 
patients at 6 months. After thyroidectomy, 41.5% of patients reported worse swallowing at the 
initial post-operative visit and this persisted in 32.1% at 6 months. 
Conclusions: A high prevalence of voice and swallowing impairments exist in older patients. 
After thyroidectomy there is a high incidence of patient-reported further impairment in voice and 
swallowing which may persist at 6 months post-operatively. Older patients should be counseled 
appropriately regarding higher risk of voice and swallowing impairments following thyroidectomy 






Despite the reported low incidence of temporary or permanent recurrent laryngeal nerve 
(RLN) injury (0.01–15.4%) and superior laryngeal nerve injury (0.0 – 4.6%), voice and 
swallowing symptoms after total thyroidectomy are increasingly prevalent (24, 25, 53). Studies 
including patients with nerve injury report rates of adverse voice and swallowing outcomes of up 
to 87% with only up to 7% persisting beyond 6 months (53-62). As such, most voice and 
swallowing impairments following thyroidectomy are not related to demonstrable impaired nerve 
function.  
Prior studies have identified reasons for voice and swallowing impairments including 
intubation-related trauma, surgical trauma, disruption of the vascular supply and drainage of the 
larynx, disruption of strap musculature, laryngotracheal fixation with impaired vertical 
movement, and psychologic reasons (63-66). Although age has not been identified as a risk 
factor, Papadakis and colleagues demonstrated that patients above 40 years of age suffer from 
voice changes for a longer duration postoperatively compared to younger patients (67). 
However the impact of thyroidectomy specifically on older adults (age ≥ 65) is unknown and 
prior studies were performed on mostly younger adults. Dysphagia and dysphonia after 
thyroidectomy can significantly impact one’s quality of life, affecting social interactions, 
compliance with medications, and nutritional intake (68).  
With increasing age, deterioration of the cartilaginous and myoelastic structures of the 
larynx can occur and can contribute both to presbyphonia and dysphagia. Atrophy of the upper 
esophageal sphincter can affect swallowing as well. Thus, aging alone can cause changes in 
the structure, motility, and coordination of swallowing. Upon retrospective review of 925 patients 
over the age of 65 undergoing thyroidectomy over a one-year period, 26% of patients reported 
alteration in voice quality or swallowing. However, almost half of patients were not specifically 
questioned regarding voice and swallowing alterations in post-operative follow-up and only 24% 
reported no changes (69). This is likely an underestimate of the true incidence as patients are 
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likely to under-report changes and they are not typically seen again after the first post-operative 
visit. 
We hypothesize after surgical manipulation older patients are at higher risk of having 
voice and swallowing changes. Therefore, the aim of the present study is to prospectively 
assess the incidence of patient-reported voice and swallowing changes following thyroidectomy 
in the absence of RLN injury. 
 
Material and Methods 
Patients were recruited from 4 endocrine surgical clinics at a single institution between 
May 1, 2017 and July 31, 2020. Demographic and clinical data including risk factors for 
development of voice or swallowing changes were recorded. Surveys, including the validated 
Voice Handicap Index (VHI) and Dysphagia Handicap Index (DHI), were administered pre-
operatively and at several time points post-operatively including within 4 weeks, at 3 months, 
and at 6 months. In the VHI (30-items) and DHI (25 items) each item is rated from 0 to 4, with 4 
indicating greater impact. The VHI and DHI both have subscales, which, include functional, 
emotional, and physical. For the VHI, the functional subscale describes the impact of a person’s 
voice disorder on their daily activities. The emotional subscale represents a patient’s affective 
response to a voice disorder, and the physical subscale represents self-perceptions of laryngeal 
discomfort and voice output characteristics.  Similarly, the DHI functional, emotional, and 
physical subscales attempt to measure the impact of dysphagia on quality of life in each 
respective area. All thyroid procedures were performed with The Nerve Integrity Monitoring 
System (NIM, Medtronic, Jacksonville, FL) with endotracheal tube sizes 6.0 or 7.0. Patients 
were excluded if nerve signal was lost during the procedure, nerve injury during the procedure, 




Scores for each questionnaire, frequency of complaints, and mean changes pre- and 
post-operatively at each time point per patient were tabulated. Mean changes (with SD and 95% 
confidence interval) in scores on each of the surveys post-surgery compared to pre- was 
calculated to describe the extent and variability of with-in person changes, overall, and by each 
group including those with and without changes. The difference in survey scores from pre- to 
post-thyroidectomy was assessed using a paired t-test overall and by each group.  The 
frequency of specific complaints and changes in specific survey questions was also tabulated to 




Approximately 200 patients were approached for enrollment. Of the 70 patients enrolled, 
53 older adults completed 6 month follow up (Table 1). The remaining 17 patients have just had 
surgery, but not enough time for follow up. Of this cohort, the mean age was 71.1 (range 65-94). 
Majority of patients were female gender (71.7%), of white race (86.8%), and non-smokers 
(58.5%). Mean BMI of this cohort was 29.8 (range 19.2-48.9). Of this cohort, 13.2% had a 
history of gastro-esophageal reflux disease (GERD), 28.9% had a prior malignancy, and 11.3% 
had a Charlson Comorbidity Index of 6 or greater. The most common pre-operative diagnoses 
included a suspicious thyroid nodule (37.7%), a multinodular goiter (35.9%), and thyroid cancer 
(13.2%). Regarding the operative procedure performed, 35.9% underwent hemithyroidectomy 
and 60.4% underwent total thyroidectomy. Final pathology was benign in 54.7% and malignant 
in 45.3%. Of this cohort, 67.9% had abnormal scores on the pre-operative VHI and 77.4% had 
abnormal scores on the DHI. Mean pre-operative total VHI score was 7.3 (SD 9.7) and mean 







 At the pre-operative evaluation, the most frequent positive responses were in the 
physical and functional subscales. The most frequent positive responses to the physical 
subscale questions were “The sound of my voice varies throughout the day” reported by 44% 
followed by “I run out of air when I talk” reported by 34.6%. The most frequent responses were 
to the functional subscale of questions were “My voice make it difficult for people to hear me” in 
37.7%, “People have a difficult time understanding me in a noisy room” in 35.8%, and “My 
family has difficulty hearing me when I call them throughout the house” in 32.1%. The frequency 
of these positive responses increased in the initial post-operative period, but went back to 
baseline by 6 months post-operatively.  
 In the early post-operative period, there was an increased frequency of responses to 
physical subscale questions. “The clarity of my voice is unpredictable,” which was reported by 
21% pre-operatively, but by 37% in the early post-operative period and by 26.9% at 6 months 
post-operatively. “My voice is worse in the evening,“ which was reported by 15.4% in pre-
operative period, 33.3% in the postoperative period, and 32.1% up to 6 months postoperatively. 
“My voice ‘gives out’ on me in the middle of speaking” increased from 23% in the pre-operative 
period to 28% in the initial post-operative period and was reported by 32.7% at 6-months. There 
was also an increase in positive responses to an emotional subscale question of “I find other 
people don’t understand my voice problem,” which was reported by 5.6% in the pre-operative 
period and by 11.2% at 6 months.   
 Compared to the pre-operative VHI total score, post-operative VHI total scores were 
higher in 49.1% of patients at the initial post-operative visit, in 43.3% at 3 months, and in 32.1% 
at 6 months indicating worse function (Figure 1). Compared to the pre-operative assessment, 
post-operatively in the functional subscale, 47.2% of patients had higher scores early, 39.6% 
had higher scores at 3 months, and 32.1% had higher scores at 6 months indicating worse 
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function affecting daily activities (Figure 1). Compared to the pre-operative assessment, post-
operatively in the emotional subscale, 30.2% of patients had higher scores early, 35.8% had 
higher scores at 3 months, and 18.9% had higher scores at 6 months. Compared to the pre-
operative assessment, post-operatively in the physical subscale, 47.2% of patients had higher 
scores early, 43.4% had higher scores at 3 months, and 32.1% had higher scores at 6 months 
(Figure 1).  
 In examining differences in mean scores within each subscale at each post-operative 
time point, only a difference in the physical subscale of voice was seen at one month 
postoperatively (Table 2).  In the physical subscale, the mean score was 4.6 (SD 6.3) 
postoperatively, compared to 3.07 (SD 5.0) post-operatively (p = 0.03). There was no difference 
in total or other subscale scores for patients at each post-operative time point compared to the 
pre-operative time point. In summary, voice impairment was common pre-operatively, worsened 
in the early post-operative period, and 32% of patients reported voice impairments up to 6 
months post-operatively. Adverse voice outcomes affected daily activities and how patients 
heard their voice.  
Dysphagia 
At the pre-operative evaluation, the most frequent positive responses were in the 
physical subscale questions. “My mouth feels dry” was reported by 56.6%, “I cannot swallow 
food without washing it down with liquid” was reported by 45.3%, and “I cough when swallowing 
liquids” was reported by 43.4%. On the self-reported dysphagia severity scale, 83% of patients 
noted that their swallowing was normal (score of 1-2) and 17% reported a moderate problem 
(score 3-5). 
After thyroidectomy, the symptoms reported pre-operatively had minimal change. 
However, patients more frequently reported another physical subscale question of “I cough 
while eating solid food”, which was reported by 28% pre-operatively, up to 40% in the early 
post-operative period and dropped back down to 27% at 6 months. Interestingly, emotional 
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subscale questions of “I am nervous about my swallowing problems” increased from 9.4% 
baseline to 17.2 early post-operative period back to baseline at 6 months and “I have a fear that 
I may choke and suffocate with food in the throat because of my swallowing problem” from 17% 
at baseline to 25.5% early postop to 19% at 6 months. On the self-score, in the early post-
operative period, 21.3% reported moderate problem and at 6 months, 10% reported a moderate 
problem, and 1.9% reported a severe problem.  
Compared to the pre-operative DHI assessment, post-operative total DHI scores were 
higher in 41.5% of patients at the initial post-operative visit, in 43.4% at 3 months, and in 32.1% 
at 6 months indicating worse function (Figure 2). Compared to the pre-operative assessment, 
post-operatively in the functional subscale, 35.8% of patients had higher scores early, 37.7% 
had higher scores at 3 months, and 18.9% had higher scores at 6 months indicating worse 
function (Figure 2). Compared to the pre-operative assessment, post-operatively in the 
emotional subscale, 26.6% of patients had higher scores early, 34.0% had higher scores at 3 
months, and 17.0% had higher scores at 6 months. Compared to the pre-operative assessment, 
post-operatively in the physical subscale, 39.6% of patients had higher scores early, 39.6% had 
higher scores at 3 months, and 32.1% had higher scores at 6 months (Figure 2). 
However, no significant differences in mean scores between pre-operative and post-
operative scores in the total score, the physical, functional or emotional subscales was 
observed (Table 3). Therefore, swallowing impairments were prevalent pre-operatively, 
worsened in the initial post-operative period in all aspects affecting activities of daily living, 









To the best of the authors’ knowledge, this is the first study to demonstrate that 67.9% 
and 77.4% of older patients have voice and swallowing impairment prior to thyroidectomy, which 
worsens post-operatively with changes seen up to 6 months after surgery. Older patients also 
have a higher frequency of adverse voice and swallowing outcomes both in the early post-
operative period as well as at 6 months post-operatively in the absence of intra-operatively 
documented recurrent laryngeal nerve injury reported by younger patients in prior studies.  Prior 
studies have demonstrated that < 10% of younger patients have persistent voice or swallowing 
changes at 6 months postoperatively (70). Voice and swallowing impairments persisted in 
almost 1/3 of patients at 6 months post-operatively and affected performance of daily activities 
in addition to self-perception.  
Our findings of specific voice complaints in the pre-operative periods were consistent 
with prior studies have demonstrated that voice changes associated with aging include 
hoarseness and breathiness, vocal fatigue, instability and crackling, while voice amplitude and 
frequency are preserved (71, 72). The most common responses in the pre-operative period 
reflected breathiness and vocal instability. Age-related changes associated with dysphagia 
include reduced bulk and possible increased sensitivity of the vocal cords which was reflected in 
the high frequency of responses to coughing when drinking liquids (73). This aspect seemed to 
be exacerbated by thyroidectomy as post-operatively there was a higher frequency of positive 
responses to coughing when eating solid food, which would imply further increased sensitivity to 
the vocal cords. Aging also results in lower salivary flow rates, which in combination with certain 
medications, can lead to xerostomia and was also reflected in the high frequency of responses 
to the question about dry mouth (73). 
   
The data in the literature assessing the association of voice and swallowing changes 
after thyroidectomy without RLN injury in relation to age is limited. However, several studies 
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have described the objective voice and swallowing changes associated with thyroid surgery 
across all age groups. In a survey completed by 4,426 members of the Thyroid Cancer 
Survivors' Association, 51% of participants who had undergone thyroidectomies reported 
postoperative voice disorders, most commonly complaining of hoarseness or a decreased ability 
to speak loudly, shout, or sing (74). However, this study was unable to clearly identify those 
patients who may have incurred a nerve injury. In another study by Hong et al, acoustic analysis 
of 54 patients following thyroidectomy without nerve injury showed that speaking fundamental 
frequencies had been altered and that vocal range had been reduced in 86% of patients (56). A 
6 month prospective evaluation of 53 patients undergoing total thyroidectomy without recurrent 
laryngeal nerve injury attempted to identify a relationship between laryngeal mobility, dysphagia  
and hoarseness and found no association. Furthermore, 47% of patients reported postoperative 
swallowing difficulties, most commonly foreign body sensation in the throat. In contrast to our 
study, the swallowing difficulties and laryngeal mobility impairments resolved in the majority of 
patients with only 7.6% reporting postoperative swallowing difficulties after 6 months (75).  
Similar to our study, a qualitative study of interviews with patients identified a high 
incidence of dysphagia 2 weeks after thyroidectomy. Two major themes were additionally 
identified including the concern that dysphagia symptoms produced and discovery of 
compensatory and coping strategies to mitigate symptoms of dysphagia (76). 
As the US population ages, more thyroidectomies will be performed on older adults. The 
population aged greater than 65 years, reported as 43.1 million or 13.7% of the total population 
of the United States in 2012, is estimated to double by 2050 to 83.7 million and comprise 20.9% 
of the total population (77). Additionally, the number of total thyroid nodule related operations 
has increased from 99,613 in 2006 to 130,216 in 2011, representing a 31% increase in a 5 year 
period (78). Thus, the number of older patients undergoing total thyroidectomies is expected to 
grow with time. There is a paucity of data regarding the impact of thyroidectomy on older adults. 
The impact of these changes on quality of life is significant (68). Voice and swallowing 
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alterations have a daily impact on interaction with family and friends, quality of life, participation 
in society, and difficulty taking medications, which may affect compliance.  Furthermore, 
swallowing difficulties can lead to weight loss, nutritional deficits, and an elevated risk of 
pneumonia (79, 80). These difficulties may be exaggerated in older adults and can, in turn, 
increase the risk becoming more vulnerable to stressors. Our study further demonstrated that 
adverse voice and swallowing outcomes impacted activities of daily living, emotional state of 
patients, and how patients perceived their own voice and swallowing. Additionally, 32% had 
impairments at 6 months post-operatively, which is much greater than the 7% reported for 
younger patients.  
Our study has several limitations. Voice and swallowing changes were elicited from 
surveys and thus recall bias may have affected responses. Reported impairments were 
analyzed on their presence or absence, however the degree, severity, and duration can vary in 
quality.  There was a lack of standardized objective assessment of voice and swallowing 
function in all patients. Our sample size limited extensive analysis of risk factors but did 
demonstrate some trends. There are medications, such as bisphononates, steroids, 
anticholinergic drugs for urinary retention, and tricyclic anti-depressants and neuroleptics that 
can exacerbate age-related dysphagia and we did not take those into account. Similarly, we did 
not factor in prior occupational voice use. Larger studies need to be performed to assess 
associations between clinical and demographic factors. 
In conclusion, post-operative voice and swallowing impairments are prevalent in older 
patients and there is a high incidence of further impairment of voice and swallowing after 
thyroidectomy which can persist at 6 months following thyroidectomy. It is imperative to counsel 
patients regarding this and consider early referral for therapy. Future studies are needed to 





Table 1. Patient Demographic and Clinical Characteristics (n = 53) 
 
Characteristic  
Mean Age ± SD (range) 71.1 ± 5.7 (65-94) 
Female gender 38 (71.7) 
Race/Ethnicity 
   White 
   Black 





Mean BMI ± SD (range) Kg/m2 29.8 ±6.6 (19.2-48.9) 
Smoking Status 
   Current 
   Former 





Gastroesophageal Reflux Disease  7 (13.2) 
Prior Malignancy 15 (28.9) 
CCI Scores 
   2 
   3 
   4 
   5 








   Graves’ disease 
   Multinodular goiter 
   Thyroid nodule 
   Suspicious thyroid nodule 







Pre-operative dysphonia 36  (67.9) 
Pre-operative dysphagia 41 (77.4) 
Procedure 
   Hemithyroidectomy 
   Total thyroidectomy 






   Benign 












Table 2. Paired t-test for difference in mean post-operative Voice handicap index survey 
scores compared to pre-operative scores 
 




   Functional 
   Emotional 
   Physical* 
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Table 3.  Paired t-test for difference in mean post-operative dysphagia handicap index 
survey scores compared to pre-operative scores 
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Figure 1. Percentage of patients with change by at least one point  (worse, improved, no 
change) in voice as reflected by Voice Handicap Index (VHI) scores within 4 weeks, 3 
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Figure 2. Percentage of patients with change (worse, improved, no change) in swallowing 
as reflected by change in Dysphagia Handicap Index (DHI) scores within 4 weeks, 3 
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Background: Older adults experience a high incidence of adverse voice and swallowing 
outcomes after thyroidectomy. The association between frailty status and these changes is 
unknown. The aim of this study was to evaluate the association between frailty on the incidence 
of voice and swallowing alterations after thyroidectomy. 
Materials & Methods: We performed an IRB-approved prospective longitudinal cohort study 
among older patients undergoing thyroid surgery between January 2014 and September 2016. 
Patients with RLN injury were excluded. Frailty was assessed using the Fried Frailty Phenotype 
at the initial pre-operative visit. Validated surveys including the Voice Handicap Index (VHI) and 
Dysphagia Handicap Index (DHI) were administered up to 6 months postoperatively. The 
association among risk factors, including frailty status, prior history of neck surgery, frequent 
voice use, presence of malignancy or gastroesophageal reflux disease, and smoking status and 
reported voice and/or swallowing changes was examined. Frailty was defined as frail or pre-frail. 
Results: Of 70 patients enrolled, 53 completed 6 months of follow up. Of this cohort, 21 patients 
(39.6%) were robust, 27 (51.0%) were pre-frail, and 5 (9.4%) were frail. Voice or swallowing 
impairments were reported by 8 (38.1%) robust patients compared to 23 (71.8%) frail patients in 
the initial post-operative period (p=0.015) and by 6 (28.6%) robust patients compared to 20 
(62.5%) frail patients up to 6 months post-operatively (p=0.016). Compared to robust patients, 
frail patients had a 3.65 increased odds (95%CI: 1.12-11.90) of developing a functional and 
physical voice change in the initial post-operative period and a 4.7 increased odds (95% CI: 
1.14-19.07) at 6 months in the physical subscale. Compared to robust patients, frail patients had 
3.75 increased odds (95% CI: 1.03-13.65) of developing functional swallowing impairments in 
the early post-operative period. Body mass index (BMI) and malignant pathology were also 
identified as risk factors for developing voice and swallowing changes respectively. 
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Conclusions:  Frailty may be associated with increased voice and swallowing impairments after 
thyroidectomy, however larger studies are needed to adequately identify risk factors for voice 



























Over 150,000 thyroidectomies are performed annually in the United States and 
approximately 25% of thyroidectomies are performed on older adults (age ≥ 65)  (14). The main 
indications for a thyroidectomy include presence of a symptomatic, indeterminate or suspicious 
thyroid nodule, a goiter, Graves’ disease, or thyroid cancer (15). Thyroid nodules are present in 
70% of people by the age of 70 (16). Additionally, the incidence of thyroid cancer has doubled 
over the past couple of decades. Furthermore, the U.S. Census Bureau estimates a 58% 
increase in the population aged ≥ 65 years and an 85% increase in those aged ≥ 85 years by 
2035 (ref).  Thus, the number of thyroidectomies performed in older adults will continue to rise 
annually.  
While overall complication rates are low, older adults undergoing thyroidectomy have a 
high incidence of voice and swallowing impairments following thyroidectomy despite intact 
laryngeal nerves. Possible reasons for this may be due to violation of the strap muscles, 
manipulation of the cricothyroid muscles, and scarring in the laryngo-tracheal region. Risk 
factors that have been identified in prior studies for developing postoperative changes in voice 
or swallowing include presence of gastroesophageal reflux disease (GERD), frequent voice use, 
smoking history, prior neck surgery, and arytenoid trauma due to endotracheal intubation (53, 
59, 81, 82).  Although several studies have evaluated risk factors for adverse voice and 
swallowing outcomes, older adults represent a unique and under-represented population. 
Deterioration of the cartilaginous and muscular structures of the larynx that occur normally with 
aging can contribute to changes in voice in addition to changes in the structure, motility, 
coordination, and sensitivity of the swallow process (30). These changes may also make one 
more susceptible to surgical manipulation and thus should be assessed as a risk factor for 
developing impaired voice and swallowing post-thyroidectomy 
 Frailty is a unique domain and indicator of physiologic reserve characterized by 
increased vulnerability to unfavorable outcomes, decreased homeostatic reserves and lower 
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resistance to stressor events such as surgery (35, 36).  The frailty phenotype (shrinking, 
weakness, exhaustion, low physical activity, slowed walking speed) was first described in a 
cohort of 5,317 community dwelling older adults (Cardiovascular Health Study, CHS (37). It is in 
part a sarcopenia phenotype. The composite measure has predictive validity for development 
of, among other adverse events, cardiovascular disease (38), venous thromboembolism (39), 
disability, hospitalization, and death (40).  Furthermore, in 594 patients undergoing a general 
surgical procedure pre-operative frailty was associated with an increased risk for postoperative 
complications, length of stay, and discharge to a skilled or assisted living facility (41). Multiple 
studies have been published citing the association between frailty and poor outcomes after 
surgery, specifically transplant surgery, general surgical procedures, and cardiac procedures.   
For example, frail patients who undergo kidney transplant, are more likely to experience post-
operative delirium, delayed graft function, longer length of stay, early hospital readmission, 
lower health-related quality of life, and mortality (42-47). Frailty patients who undergo cardiac 
procedures have higher mortality and poor recovery (48, 49). In common general surgery 
operations, including thyroidectomy, frailty as measured by a modified frailty index was 
associated with increased per-operative morbidity (50). Frail patients are also noted to have 
higher voice handicap index (VHI) scores when compared to robust patients (52).  However, 
use of this phenotype to predict which patients are more likely to develop post-operative 
adverse swallowing and voice outcomes after thyroidectomy has not yet been performed even 
though frailty is associated with worse outcomes after surgery and with presbyphonia. 
 Therefore the main objective of this study is to evaluate the association between frailty 
and incidence of post-operative alterations in voice and swallowing post-thyroidectomy. 
 
Methods 
Patients were recruited from 4 endocrine surgical clinics at a single institution between 
May 1, 2017 and July 31, 2020. Demographic and clinical data was collected and recorded. 
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Surveys were administered pre-operatively and at several time points post-operatively including 
within 4 weeks, at 3 months, and at 6 months. Administered surveys included the validated 
Voice Handicap Index (VHI) and Dysphagia Handicap Index (DHI). In the VHI (30-items) and 
DHI (25 items) each item is rated from 0 to 4, with 4 indicating greater impact. A voice or 
swallowing impairment was defined as any increase in score on the VHI or DHI respectively.  
 
Frailty Assessment 
Frailty as defined by Fried et al., was measured using a previously validated scale evaluating 5 
binary criteria and calculated using the Hopkins frailty calculator 
(http://www.johnshopkinssolutions.com/solution/frailty/). Individuals with >=3 criteria are 
designated as “frail”, 1-2 as “pre-frail,” and 0 as “robust”.  
Statistical Analysis 
Frailty, average total and subscale VHI and DHI survey scores, and change in survey 
scores were assessed with a Mann Whitney U test. Frailty phenotype was dichotomized to 
robust versus pre-frail or frail. A Pearson’s chi-squared or Fisher’s exact was used to evaluate 
an association between voice or swallowing changes overall (present or absent) and in each 
subscale and frailty status. Mann Whitney U test was used to examine difference in mean 
scores by frailty status. Logistic regression model was used to examine risk factors, including 
age, sex, BMI, presence of GERD, smoking status, extent of thyroid procedure 
(hemithyroidectomy versus total thyroidectomy), thyroid pathology, and frailty status for 
increased scores on total and subscale VHI and DHI indicating worse function. Age and BMI 
were treated as both a continuous variable and categorical variables with age dichotomized into 








Of the 70 patients enrolled, 53 older adults completed 6 month follow up. The age range 
was 65-94 (mean age was 71.1). Most patients were female gender (71.7%), as expected with 
thyroid disease and of white race (86.8%). The majority of patients were non-smokers (58.5%), 
non-obese (58.5%), with a Charlson comorbidity index of <6 (88.7%) and did not have a history 
of gastro-esophageal reflux disease (GERD) or prior malignancy. The most common pre-
operative diagnoses included a suspicious thyroid nodule (37.7%), a multinodular goiter 
(35.9%), and thyroid cancer (13.2%). Most patients underwent total thyroidectomy (60.4%) and 
most had benign final pathology (54.7%).  Majority of patients had abnormal scores on the pre-
operative VHI (67.9% ) with mean score of 7.3 (SD 9.7). Majority of patients also had abnormal 
scores on the pre-operative DHI (77.4%) with mean pre-operative DHI score of 4.0 (SD 5.3). 
Patient Characteristics by Frailty Status 
Regarding the frailty phenotype, 21 patients (39.6%) were robust, 27 (51.0%) were pre-
frail, and 5 (9.4%) were frail (Table 1).  The majority of pre-frail/frail individuals in the sample, as 
compared to robust, were female, of white race, non-smokers, and had a mini-cognitive score of 
3-5. Both groups had similar mean age and mean BMI. Among robust patients, the most 
common diagnoses were a suspicious thyroid nodule in 52.4% followed by a multinodular goiter 
in 33.3%, whereas in the non-robust group, the most common diagnoses were a multinodular 
goiter in 37.5% followed by a suspicious nodule in 28.1% (Figure 1). At baseline, abnormal VHI 
scores were present in 57% of robust patients and 75% of frail patients, and abnormal DHI 
scores were present in 67% of robust patients and 84% of frail patients.   
 
Voice or Swallowing Impairments Post-thyroidectomy by Frailty Phenotype 
Of this cohort, 8 (38.1%) robust patients compared to 23 (71.8%) frail patients had 
higher VHI or DHI scores in the initial post-operative period (p=0.015). At 6-months post-
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thyroidectomy, 6 (28.6%) of robust patients versus 20 (62.5%) of frail patients had voice or 
swallowing impairments (p=0.016). In the initial post-operative period, the greatest differences in 
voice impairments between frailty phenotypes were seen in the functional and physical 
subscales with 6 (28.7%) of robust patients compared to 19 (59.4%) frail patients reporting 
voice impairments for each of the subscales (p=0.028) (Figure 2a). The difference between 
frailty phenotypes for the physical subscale of voice persisted at 6 months with 3 (14.3%) robust 
patients compared to 14 (43.5%) frail patients reporting worse function in this domain (p=0.025). 
Regarding swallowing dysfunction, in the initial post-operative period, the greatest differences 
between frailty phenotypes was seen in the functional subscale with 4 (19.1%) robust patients 
and 15 (46.9%)  frail patients reporting impairment (p=0.046). At 6 months, no significant 
differences were seen between frailty phenotypes in dysphagia handicap index total or subscale 
scores (Figure 2b).  
Association between Frailty and Voice Impairments Post-thyroidectomy 
Comparing robust to nonrobust patients, 33.3% versus 59.3% reported worse scores in 
the early post-operative period (p=0.06) whereas 19.1% compared to 40.6% reported worse 
scores at 6 months (p=0.100). On univariate logistic regression, compared to robust patients, 
frail patients had a 3.65 increased odds (95%CI: 1.12-11.90) of having a worse score in the 
functional subscale of voice in the early post-operative period compared to the pre-operative 
period indicating a change in daily activities due to voice (Table 3a).  Frail patients had a 3.65 
increased odds (95% CI:1.12-11.90) in the initial post-operative period and a 4.7 increased odds 
(95% CI: 1.14-19.07) 6 months post-operatively of having a worse score compared to pre-
operative in physical subscale of voice, indicating that this impairment influenced self-perception 
(Table 3b). Frailty was not significantly associated worsening of total VHI scores in the early 
postoperative period (OR=2.92, 95% CI:0.93-9.22) or at 6 months postoperatively (OR= 2.91 
95% CI: 0.79-10.65). 
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In evaluating risk factors for developing voice changes in the early post-operative period, 
increasing BMI was associated with a 1.11 increased odds (95% CI: 1.01-1.22) of developing 
voice changes (Table 2). Age, sex, race, GERD, smoking status, procedure, final pathology, 
pre-operative dysphagia, pre-operative dysphonia were not associated with developing voice 
changes post-operatively. An exploratory model with frailty, age, and sex was performed an the 
association between frailty and changes was attenuated.  
Association between Frailty and Swallowing Impairments Post-thyroidectomy 
In the early post-operative period, 28.5% of robust patients compared to 50%  of frail 
patients reported worse scores. At 6 months post-operatively, 19.1% of robust patients 
compared to 43.8% of frail patients reported worse scores at 6 months (Figure 2b). In the early 
post-operative period, 19.1% of robust and 46.9% of frail patients felt that the swallowing 
change impacted their daily activities (p=0.039) and at 6 months post-operatively, 4.8% robust 
and 9% of frail patients felt that their swallowing impairment affected their daily activities 
(p=0.069) . Compared to robust patients, frail patients had 3.75 increased odds (95% CI: 1.03-
13.65) of developing swallowing impairments that impacted their daily activities as indicated by 
worse score on the functional subscale in the early post-operative period, however, this 
association dissipated at 6-months postoperatively. Frailty was not associated with impaired 
swallowing overall or in the physical or emotional subscales in the early or late post-operative 
periods.  
In evaluating risk factors for developing swallowing impairments in the early post-
operative period, age, sex, race, GERD, smoking status, frailty, procedure, final pathology, pre-
operative dysphagia, pre-operative dysphonia were not associated with developing any 
swallowing impairments (Table 3). However, at 6 months post-operatively patients with 
malignant final pathology had 4.8 increased odds (95%CI: 1.37-16.79) of developing swallowing 





To the authors’ knowledge, this is the first prospective longitudinal study to assess the 
association between frailty and post-thyroidectomy impairments in voice and swallowing. Frail 
patients reported voice and swallowing impairments both in the early postoperative period as 
well as up to 6 months post-operatively 20-30% more frequently than robust patients. Frail 
patients had a 3.65 increased odds (95% CI:1.12-11.90) in the initial post-operative period and 
a 4.7-fold increased odds (95% CI: 1.14-19.07) 6 months post-operatively of developing an 
alteration in physical subscale voice and a 3.75 increased odds (95% CI: 1.03-13.65) of 
developing swallowing impairments that impacted their daily activities as indicated by worse 
score on the functional subscale in the initial post-operative period. 
Voice impairments can have adverse effects on activities or functioning in daily life, 
emotional consequences, and in physical domains of a patient’s quality of life.  Prior studies 
performed predominantly in younger patients have documented voice impairment after thyroid 
surgery in up to 40% of patients without any nerve injury. Other studies have identified risk 
factors for voice impairment including age of 45-54 years, Black or Asian race, presence of 
GERD, or malignant pathology (83). In a study by Akyildiz and colleagues of 36 patients who 
underwent thyroidectomy, females and males had different degrees of deterioration and 
amelioration of acoustic voice parameters (84). Similar to our study, another study of 54 patients 
found that the above risk factors did not predict post-operative voice changes, but only a voice 
change at the initial post-operative appointment predicted a voice change at 3 months (66).  
Voice intensity is known to decrease with age due to atrophy of the cartilaginous and 
muscular structures that support the larynx and increasing age may be associated with higher 
VHI scores (85). Of our population, 67% reported a voice impairment prior to surgery, however, 
there was no association between age or frailty with preoperative voice impairment. Additionally, 
pre-operative voice impairment was not a risk factor for post-operative voice impairment. Voice 
changes following thyroid surgery are likely underrecognized likely in part due to limited use of 
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scales for ascertainment. The etiology of voice impairment is also unclear but may include 
dissection of the overlying strap musculature, laryngeal irritation or edema from airway 
management, or scar tissue formation.   
This dissection may similarly lead to dysphagia or alterations in swallowing post-
thyroidectomy. Prior studies in predominantly younger patients have demonstrated that retained 
boluses of food or impaired swallowing in approximately 40% after thyroidectomy (86-89). In 
contrast to our study, the major risk factor for post-operative swallowing impairment that has 
been identified in a prior study includes presence of GERD, which is associated with decreased 
laryngopharyngeal sphincter pressure (90). Our study did not demonstrate an association 
between GERD and adverse swallowing outcomes post-thyroidectomy. The only other risk 
factor that was previously identified in a retrospective review was age >50 (69). We additionally 
identified that malignant pathology was associated with swallowing impairments. While the 
etiology for this is not completely clear, it may be due to increased dissection.   
The increased dissection around the muscular and cartilaginous larynx may be less 
tolerated by older patients who have an atrophied support structure.  Frailty, in part a 
sarcopenia phenotype, may be used to help predict which patients would be more susceptible to 
these changes. The understanding of the association between frailty and adverse outcomes in 
older patients undergoing the stress of surgery has significantly expanded in the past decade. 
Studies have demonstrated that frail older patients experience increased complication rates and 
prolonged recovery after a wide range of elective, emergent, and common ambulatory surgical 
procedures(50, 91-95). However, our study is the first to demonstrate that voice and swallowing 
changes post-thyroidectomy, which may arise in part due to laryngeal muscle dissection, are 
increased in frail patients and affect their ability to function in daily activities in addition to alter 
self-perception up to 6 months postoperatively.  
 Our study has several limitations including our sample size and lack of objective 
assessments to correlate to subjective findings.  Multiple thyroid pathologies were included and 
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we also included both hemi- and total thyroidectomies.  However, extent of surgery was not 
associated with developing voice or swallowing impairments. There was also a selection bias in 
that patients were recruited from surgical clinics and some patients may have never been 
referred to surgery. Our sample size limited the ability to adequately test if an association 
between frailty and voice or swallowing changes persists after age adjustment. Future studies 
with a larger sample size, objective assessments, longer follow-up with testing associations 
between specific aspects of the phenotype, and assessment of sex and frailty interactions, are 
needed to further elucidate the duration and intensity of these changes, ascertain risk factors, 
and identify interventions to mitigate these outcomes. In summary, pre-frailty/frailty is associated 
with adverse voice and swallowing outcomes post-thyroidectomy that can affect an older 

























Age (mean SD) in years 70.6 ± 4.7 (65-83) 71.4 ± 6.3 (65-94) 
Female 11 (52.3) 27 (84.4) 
Race 
   White 
   Black 









BMI (Kg/m2) 29.7 ± 5.7 30.0 ± 7.1 
Smoking 
   Current 
   Former 









GERD 3 (14.3) 4 (12.5) 
Prior Malignancy 5 (23.8) 10 (31.3) 
Mini-cognitive Score 
  2 








   Graves’ disease 
   Thyroid cancer 
   Multinodular goiter 
   Thyroid nodule 













Malignant Final Pathology 10 (47.6) 14 (43.8) 
Pre-operative dysphonia 12 (57) 24 (75) 
























Table 2. Difference in mean survey scores by frailty phenotype assessed by Mann 
Whitney U test 
 Robust 
(n = 21) 
Pre-Frail/Frail 
(n = 32) 
p-value 
Voice    
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   Functional 
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Dysphagia    
Preoperative 
   Functional* 
   Emotional 
   Physical* 
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Table 3a. Unadjusted associations between patient factors and increased VHI score early 
(within 4 weeks) post-thyroidectomy.  
 
Patient and Clinical 
Factors 
Total Score 
OR (95% CI) 
Functional  
OR (95% CI) 
Physical 
OR (95% CI) 
Age 1.04 (0.94-1.14) 1.07 (0.97-1.19) 1.05 (0.95-1.16) 
Sex 0.40 (0.12-1.41) 0.18 (0.04-0.75) 0.45 (0.13-1.57) 
Race 1.04 (0.28-3.9) 0.70 (0.18-2.75) 1.11 (0.30-4.16) 
BMI 1.11 (1.01-1.22)* 1.12 (1.01-1.23) 1.06 (0.97-1.16) 
Smoking status 0.78 (0.26-2.34) 0.65 (0.22-1.96) 2.29 (0.32-7.90) 
GERD 2.97 (0.52-16.95) 3.25 (0.57-18.52) 1.59 (0.32-7.90) 
Procedure 2.12 (0.69-6.87) 1.93 (0.61-6.09) 2.74 (0.84-8.93) 
Final pathology 0.79 (0.27-2.34) 1.23 (0.42-3.64) 0.91 (0.31-2.68) 
Frail Phenotype 2.92 (0.9-9.2) 3.65 (1.12-11.90) 3.65 (1.12-11.90) 
Pre-operative 
dysphonia 
1.1 (0.3-3.5) 1.43 (0.45-4.58) 2.04 (0.62-6.74) 
Pre-operative 
dysphagia 
1.5 (0.4-5.4) 2.1 (0.55-8.08) 2.1 (0.55-8.08) 
 
Table 3b. Unadjusted associations between patient factors and increased VHI score 6 
months post-thyroidectomy. 
Patient and Clinical 
Factors 
Total Score 
OR (95% CI) 
Functional  
OR (95% CI) 
Physical 
OR (95% CI) 
Age 0.95 (0.85-1.07) 0.95 (0.84-1.06) 1.0  (0.90-1.11) 
Sex 1.43 (0.38-5.39) 2.33 (0.56-9.71) 4.2 (0.84-21.5) 
Race 1.25 (0.32-4.88) 1.24 (0.32-4.89) 0.73 (0.16-3.38) 
BMI 0.99 (0.90-1.08) 1.04 (0.95-1.13) 1.01 (0.93-1.10) 
Smoking status 1.01 (0.56-1.84) 1.01 (0.56-1.84) 4.23 (0.84-21.6) 
GERD 1.71 (0.34-8.69) 3.38 (0.66-17.25) 0.83 (0.14-4.77) 
Procedure 2.32 (0.63-8.53) 3.73 (0.91-15.29) 1.53 (0.44-5.28) 
Final pathology 1.11 (0.35-3.53) 1.11 (0.35-3.53) 0.78 (0.24-2.51) 
Frail Phenotype 2.91 (0.79-10.65) 2.91 (0.79-10.65) 4.67 (1.14-19.07) 
 
 
Table 4. Exploratory age and sex adjusted associations between patient factors and early 
(within 4 weeks) voice impairment post-thyroidectomy 
         
 
 Total Score Functional 
Subscale 
Frail Phenotype 2.45 (0.68-8.79) 2.60 (0.66-10.22) 
BMI 1.11 (1.01-1.24) 1.15 (1.02-1.29) 
Age 1.03 (0.97-1.16) 1.11 (0.96-1.30) 







Table 5. Unadjusted associations between patient factors and early (within 4 weeks) 




Total Score  
OR (95% CI) 
Functional  
OR (95% CI) 
Physical 
OR (95% CI) 
Age 1.02 (0.93-1.12) 0.96 (0.86-1.07) 1.02 (0.93-1.12) 
Sex 0.92 (0.27-3.10) 0.86 (0.24-3.0) 1.02 (0.30-3.46) 
Race 1.37 (0.36-5.17) 1.71 (.45-6.53) 0.92 (0.24-3.61) 
BMI 1.01 (0.93-1.10) 0.96 (0.87-1.05) 1.0 (0.92-1.09) 
Smoking status 1.82 (0.60-5.54) 2.04 (0.65-6.39) 1.5 (0.50-4.63) 
GERD 1.07 (0.21-5.32) 1.04 (0.28-7.07) 0.57 (0.10-3.25) 
Frailty 2.50 (0.77-8.08) 3.75 (1.03-13.65) 3.2 (0.94-10.84) 
Procedure 2.8 (0.83-9.5) 4.74 (1.16-19.32) 2.49 (0.73-8.46) 









    
 
 
Table 6. Exploratory age and sex adjusted association between patient factors and early 
(within 4 weeks) swallowing impairment post-thyroidectomy 
 
          
 Overall Score 
OR (95% CI) 
Functional 
Subscale 
OR (95% CI) 
Frail Phenotype 2.80 (0.73-10.65) 6.35 (1.22-32.89) 
Malignant pathology 2.88 (0.88-9.45) 5.84 (1.50-22.70) 
Age 1.02 (0.92-1.13) 0.94 (0.83-1.06) 







































Figure 2a. Percentage of patients with worse Total Voice Handicap Index scores post-
operatively compared to preoperatively by total and subscale scores. 
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Introduction Older adults with well-differentiated thyroid cancer pose unique management 
challenges for clinicians who must weigh the risks of surgery and anesthesia with the survival 
benefit gained from treating their malignancy. Prior studies have demonstrated that older adults 
tend to undergo less treatment for their thyroid cancer. We outline a study, which aims to 
understand how surgical recommendations vary based on patient characteristics, extent of 
disease, and surgeon characteristics.  
Methods and analysis We outline a protocol for the development of a discrete choice 
experiment (DCE), which uses a survey design. We describe both the qualitative methods used 
to initially design the DCE and the pilot test conducted to refine the DCE. Regression analysis 
will be used to refine the results. 
Ethics and dissemination This study has been approved by our Institutional Review Board. 
Introduction 
The population of older adults in the United States (US) is on the rise. The US Census 
Bureau estimates a projected 58% increase in the population aged 65 and older and an 85% 
increase in the population age over 85 by the year 2035(96). The incidence of thyroid cancer is 
also on the rise(97).  While thyroidectomy remains the gold standard to treat thyroid cancer, 
older adults (age > 65) pose unique challenges in surgical decision-making.  Management 
decisions must weigh the risks of surgery, which are increased in the presence of co-
morbidities, against the likelihood of cancer progression, morbidity, and mortality.  On one hand, 
the majority of thyroid cancers are small, slow growing, and low risk, which suggests a more 
conservative approach to treatment of thyroid cancer in older adults is reasonable(98, 99). 
Furthermore, some evidence suggests that the increase in thyroid cancer can be attributed to 
over-diagnosis due to improved and more frequent use of imaging as mortality from thyroid 
cancer has remained essentially stable(97, 100).  On the other hand, increasing patient age has 
been associated with higher rates of recurrence, worse prognosis, aggressive disease 
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characteristics, lymph node (LN) metastasis, and increased mortality suggesting perhaps a 
more aggressive surgical approach should be utilized(6, 101-103). Traditionally a total 
thyroidectomy has been performed to treat thyroid cancer, however, the most recent guidelines 
set forth by the American Thyroid Association indicate that thyroid lobectomy, or only removal of 
half of the thyroid, is acceptable management for a low-risk thyroid cancer less than 4cm in size 
and also that active surveillance is acceptable for a low-risk patient with a thyroid cancer of less 
than 1cm in size(104). Despite, this recommendation, analysis of the SEER database from 
2004-2015 of patients with well-differentiated thyroid cancer demonstrated that fewer older 
adults actually underwent surgery and standard of care treatment compared to their younger 
counterparts because it was not recommended. Older adults also had a worse survival from 
their thyroid cancer raising the question: does extent of surgery impact survival? 
The reason for recommending different treatments to older adults may be multi-factorial. 
While single institution studies cite the safety of thyroidectomy in older adults, population-based 
studies demonstrate increased rates of complications and hospital length of stay(2, 3, 5, 6, 20). 
Surgeon preference, comfort, and experience may affect surgical recommendations in this 
patient population as well. Furthermore, universally accepted guidelines regarding assessment 
and management of an older adult with thyroid cancer are lacking. It remains unclear how 
surgeons currently assess older adults and decide upon treatment recommendations or lack 
thereof.  
 Discrete choice experiment (DCE), a type of conjoint analysis, is an ideal method to 
study surgeon preferences and the potential trade-offs that they are willing to make in 
recommending surgery for various patients(105). Here, we outline a study protocol to elicit 
surgeon preferences regarding treatment recommendations for older adults with thyroid cancer 
through use of DCE. The goal of this study is to develop a survey to understand the reasons for 
existence of this age-related disparity in the care of older adults with well-differentiated thyroid 
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cancer exists.  This would allow for future studies to standardize and improve the quality of care 
that is provided to older adults with thyroid disease. 
Methods and Analysis 
Rationale for using Discrete Choice Experiment (DCE) 
The DCE method is a unique quantitative technique used in health care research to elicit 
preferences, priorities, and individual features associated with particular services. While these 
methods have been mainly used to understand patient preferences, they have also been 
applied to study clinician or surgical decision-making (106-109).  DCE presents various clinical 
scenarios and forces respondents to make trade-offs among different treatment options, 
providing in depth insight into the relative importance of each characteristic, or attribute, that 
makes up that particular scenario.  For example, a clinical scenario may be composed with 
three attributes such as age, functional status, and number of co-morbidities. The range of 
values that can describe an attribute are known as levels. Levels of a particular attribute dictate 
the degree of severity or how extreme a particular attribute is.  For example, a clinical scenario 
presenting a patient can include an attribute of co-morbidity, which can then be described by 
three levels as follows:  < 1, 2-3, or ³4. This enables identification of the particular level of an 
attribute that is acceptable for a provider and what trade-offs they are willing to make in 
recommending a procedure. DCE is an ideal approach to elicit surgeon preference for extent of 
procedure or lack thereof in an older adult with thyroid cancer. This methodology can delineate 
trade-offs that surgeons are willing to make based on various patient characteristics.  
Determination of Attributes and levels 
The objective of DCE is to elicit surgical preferences considering a range of attributes 
that define a clinical scenario. A thorough iterative process of formative research involving 
literature review and qualitative methods including input from various clinicians was used to 
generate the final list of attributes included in this DCE.  First a literature review was conducted 
to identify possible factors that influence surgeon preferences in recommending a particular 
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procedure and to understand how surgeons assess older adults. A comprehensive list of factors 
influencing surgical recommendations was then generated (Table 1).  Factors influencing extent 
of surgery was also obtained from case discussions at a local monthly multi-disciplinary thyroid 
tumor board at our institution.  Members of this tumor board include endocrinologists, 
pathologists, radiologists, a radiation oncologist, endocrine surgeons, and otolaryngologists. 
Next, in-depth interviews were conducted with two endocrine surgeons and one otolaryngologist 
from high-volume endocrine surgery centers at two different institutions to understand what 
factors they use to assess an older adult’s ability to tolerate surgery in addition to factors they 
consider for determining the extent of a procedure. The list created from the literature search 
was used as a platform to initiate discussion of the topics.  These interviews were thirty-minute 
in-person interviews trying to understand which patient aspects each of the surgeons 
considered when counseling an older adult with thyroid cancer. The manner in which extent of 
disease would influence surgical recommendations was discussed as well. Multi-disciplinary 
expertise in survey design and planned statistical analysis of DCE was also obtained from 
Professors at the Bloomberg School of Public Health and the Center of Aging and Health.   
Qualitative research methods were applied to identify common themes. An initial list of 
attributes was generated including the following: clinical intuition about the patient at the initial 
surgical visit (“the eyeball test”), chronological age, number or type of co-morbidities, estimate of 
functional status, estimate of life-expectancy, calculation of a co-morbidity or a frailty index, 
number of medications, input from other providers (cardiologist, internist, geriatrician, etc.), 
presentation at a tumor board, and obtaining opinions on a social media platform, such as a 
closed Facebook group of surgeons or a society-based message board. Subjective attributes, 
such as an eyeball test, estimate of life expectancy, and presentation at a tumor board or social 
media platform were eliminated.  Attributes were then further narrowed down based on practical 
and objective assessment of an older adult in a surgical clinic and frequency of responses from 
key informant interviews. The level of each attribute was also constructed based on surgeon-
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based focus groups, literature review, and clinical expertise. The staging system for thyroid 
cancer and the guidelines set forth by the American Thyroid Association were utilized to create 
levels for chronological age and extent of disease and also provided guidance on surgical 
procedures to choose from(104). Guidance for levels of attributes assessing older adults (age ≥ 
65) was ascertained from aging literature and a co-morbidities model was created from the 
surgical literature (37, 110, 111).  
 
 
Construction of Tasks 
Tasks in DCE refer to the method in which the various attributes are presented to the 
respondents, which, in this case refers to the clinical scenario. Based on the attributes and 
levels in Table 1, 96 clinical scenarios were generated.  To simplify the presentation of 
scenarios, partial profiles containing selected attributes were created in order to mimic a block 
design. First, 4 overarching clinical scenarios based on extent of disease were created (tumor 
size < 4cm and node negative, tumor size ≥ 4cm and node negative, tumor size < 4cm and 
node positive, tumor size ≥ 4cm and node positive).  Within each of the four extent of disease 
scenarios, multiple different patients with varying levels of attributes for age, co-morbidity, and 
functional status were created. Thus, four separate extent of disease scenarios were developed 
each containing the same 24 patients with respect to other attributes (Fig 1).   This would allow 
for the respondent to have a particular extent of disease in mind and select which surgical 
option they would recommend based on only patient-related factors, while holding extent of 
disease constant. The main goal of DCE, to precisely estimate preferences, requires an efficient 
and balanced design, must be weighed against the time and ability for a surgeon to complete 
the DCE and minimize illogical combinations. Based on expert opinions, clinical scenarios that 
seemed illogical and those that were not likely to provide additional information were eliminated.  
For example, including a patient with good functional status and only 0-1 co-morbidities who is < 
55 and 55-64 seemed redundant in a patient with nodal disease and would not yield additional 
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information. To facilitate the efficient design, the four disease state scenarios were narrowed 
down to three. The final DCE consisted of three main scenarios with varying extent of disease 
(tumor size < 4cm and node negative, tumor size ≥ 4cm and node negative, tumor size < 4cm 
and node positive). Within each of the disease status scenarios, patient scenarios were also 
eliminated to yield clinically meaningful and distinct recommendations.  
 
Survey Design 
The final survey tool including the framing of the questions was developed with the 
assistance and review of the key informants from above. The survey instrument began with a 
short introduction regarding the purpose of the study.  It was then divided into three sections: 
demographic and practice information, methods of assessing fitness for surgery and gradation 
of their relative importance, and finally clinical scenarios.  Demographic and practice information 
allows the assessment of variation of preferences according to respondent characteristics. 
Practice information collected included years in practice after training, type of practice 
(endocrine surgery only versus mixed), on average number of thyroid procedures per year, and 
on average percent of patients seen that are over the age of 65.  Key informants then reviewed 
the questionnaire to check for clinical accuracy and applicability.  The Qualtrics XM (Provo, UT) 
survey interface was used to design and administer the survey tool.  This survey interface was 
chosen due to its intuitive and easy to use user interface. Respondents had the option to not 
answer a question if they wished. 
 
Pilot Testing 
Pilot testing was conducted with 15 surgeons of varying backgrounds to test the face 
validity of the survey. Feedback was used to refine the final levels for the attributes.  
Specifically, the clinical scenario incorporating tumor size was modified to be greater than 4cm 
as respondents felt that 4cm was a gray zone that could be interpreted in different ways. Survey 
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flow, font size, and skip patterns on the Qualtrics interface were also modified based on verbal 
feedback from the pilot testing. Most participants felt that the questionnaire was clear and easy 
to interpret. Under the question ascertaining how surgeons assess older adults, a few were 
unclear on the meaning of eyeball test and therefore that answer choice was modified to include 
a description “overall clinical intuition about the patient when you first meet them.” Pilot testing 
was also utilized to obtain feedback on the ease of completing the survey, feasibility, and the 
time taken to complete the survey.  The time required to complete the survey ranged from 7 
minutes to 12 minutes. All participants expressed that the scenario questions were easy to 
complete, though time consuming.  
 
PROPOSED STUDY 
Participant recruitment and Sampling Strategy 
A lack of consensus exists regarding an adequate sample size required for DCE. A 
review of 69 health care-related DCE studies published in 2012 demonstrated that 32% had 
sample sizes of less than 100 respondents and the majority of studies, 41%, had sample sizes 
between 100 to 300 respondents(112).  In a different systematic review evaluating DCE studies 
from 2005-2008 reported mean sample sizes of 100 to 300 respondents(113).  We estimate a 
sample size between 100 to 300 participants for this study.  
Eligibility criteria for participants in this study are: Surgeons practicing in the United 
States for at least one year and who are willing to participate. Two groups will be invited to 
participate: active and candidate members of The American Association of Endocrine Surgeons 
and The American Head and Neck Society, composed mostly of otolaryngologists.  Approval 
will be provided from each society for distribution to its membership. Requests for member 




Participant data from the two societies will initially be analyzed separately as their 
demographic characteristics may significantly differ.  Respondent characteristics will be reported 
and differences will be assessed using a chi-squared test. For the DCE, respondents will be 
able to choose among several procedures. Therefore, initially a multinomial logit model (MNL) 
will be utilized to understand the tradeoffs between patient characteristics (age, functional 
status, co-morbidities) and choice of procedure in the clinical scenarios(105). The analysis of 
surgeons towards a procedure will facilitate investigation of not only which patient and disease 
factors (and levels) influence their recommendations for a procedure, but also will help to 
establish the importance of those factors. A multinomial logit  (MNL) model will allow the 
examination of preference heterogeneity based on observed patient and disease characteristics 
rather than individual surgeon heterogeneity.  We plan to utilize the MNL for primary data 
analysis because the aim of our study is to focus on predictable differences. We do intend to 
explore the data with the mixed MNL and generalized MNL models, both of which can be 
performed in STATA (version and reference).  The benefit of the mixed MNL model is that it 
accounts for variation in preferences across respondents and models heterogeneity.  All 
attributes will be modeled as categorical or binary variables, although, age may be explored as 
a continuous variable. To explore preferences between groups, a regression with parameters 
interacting with surgeon age, years of experience, and practice will be run.  Tables of 
coefficients for the levels and covariates will be presented.  
 
Discussion 
 To the best of the authors’ knowledge, this is the first multi-step study to design a 
discrete choice experiment in assessing surgical decision-making for older adults with thyroid 
cancer. Our steps included literature review to identify factors utilized by surgeons to 
recommend treatments, key informant interviews, identification of key attributes and levels, 
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generation of clinical scenarios, and pilot testing. In this study, we built upon Coast and 
colleagues who recognized a two-step process to develop a DCE (114).   
While DCE was originally utilized for health economics, it has been increasingly utilized to 
understand patient preferences mostly for treatments for diseases such as muscular dystrophy, 
lung cancer, leukemia, diabetes, and hepatitis C (115-119).  It has been less frequently used to 
understand clinical decision-making, but most often used to understand treatment 
recommendations by gastroenterologists or surgeons for hepatocellular carcinoma (106, 107, 
120). To our knowledge it the first time that a DCE would be constructed to understand 
treatment recommendations for thyroid cancer. 
ISPOR, the professional society for health economics and outcomes research, created a 
task force to delineate key stages to develop a DCE (121). The construction of attributes and 
levels requires qualitative methods and mixed methods to generate a list of attributes and 
levels. A meta-analysis performed to evaluate consistency within published DCE’s 
demonstrated that studies varied in number of attributes, which ranged from 3-16, however 
most included 6 attributes, 4 levels, and 73% presented 7-15 scenarios to each respondent 
(113). This is similar to our design, which used qualitative techniques to elicit factors surgeons 
felt were important and narrowed down the attributes and levels. However, our work generated 
multiple attributes, which necessitated narrowing down to several. Our approach to narrow 
down was theoretical and practical. For example, it would be difficult create a scenario for an 
attribute of an “eyeball test.”  
Once multiple clinical scenarios are generated, important structural issues to narrow 
down the scenarios, number of options in each choice set, and whether to include common 
levels of attributes in each choice set need to be addressed. Two broad approaches exist to 
constructing choice sets including theoretical and algorithmic and there is a lack of consensus 
as to which approach to employ (121). For our design, we employed a theoretical approach to 
narrow down clinical scenarios. However, we narrowed down the scenarios to greater than the 
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reported average. Finally, pilot testing enabled further iterative refinement in the wording of 
some of our scenarios to increase clarity. 
There are several challenges to utilizing this design to evaluate surgical decision-
making. The opinions of the key informant interviewees may not have fully captured the full 
breadth of factors that could be considered as relevant attributes, however, it is likely that it 
captured the majority in combination with a literature review. Additionally, we only captured 
opinions of surgeons, although in reality, multiple provider opinions are typically ascertained. 
The associated list of relevant attributes might include clinical scenarios where it is possible that 
interactions may exist among various attributes. Hypothetical scenarios are generated, which 
may limit the ability of the respondent to make a choice which would be the same choice if the 
patient was actually sitting in front of them. Finally, scenarios that were eliminated may provide 
additional insight to levels and attributes that are important. 
In conclusion, this study utilized a framework as outlined by the IPSOR to develop a 
discrete choice experiment in the form of a survey. The major steps included literature review, 
key-informant interviews, generation of relevant attributes and levels, narrowing down clinical 
scenarios, and pilot testing. Our approach is novel to understand surgical decision-making in 
thyroid cancer and encourages the application of this approach to understand clinic decision-











Table 1. Comprehensive List of Factors that influence surgical recommendations in  
older adults with cancer 
 
Factors 
“Eyeball Test” or overall picture 
Chronological Age 
Decision-making capacity 
Number of comorbidities 
Types of comorbidities 
Number of medications 
Estimate of functional status 
Frailty Index 
NSQIP Risk Calculator 
Comorbidity Index – charlson, 
Elixhauser 
Input from other providers 
(cardiologist, internist, geriatrician) 
Location of cancer 
Nutritional status 
Social support  
Patient preference 
Risk of post-operative complications 
Risk of anesthesia 
Reduced quality of life post-operatively 
Survival benefit 
Consensus after presentation at a 
tumor board 

























Table 2. Final Attributes and Levels to use in DCE clinical scenarios 
 
Attributes Levels 
Chronological Age <55, 55-64, 65-79, ≥ 80 
Frailty/Co-morbidity Not-frail (0-1) co-morbidity 
Pre-frail (2-3) co-morbidities 
Frail (≥ 4) co-morbidities 
Functional status Good  
Poor  
Nodal Status Positive 
Negative 
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Background: Prior studies demonstrate that older adults tend to undergo less surgery for 
thyroid cancer. Our objective was to utilize a discrete choice experiment to identify factors 
influencing surgical decision-making for older adults with thyroid cancer. 
Methods: Active and candidate members of the American Association of Endocrine Surgeons 
were invited to participate in a web-based survey. Multinomial logistic regression (MNL) was 
utilized to assess patient and surgeon factors associated with treatment choices. 
Results: Complete survey response rate was 25.7%. Most respondents were high volume 
surgeons (88.5%) at academic centers (76.9%). MNL demonstrated that patient age was the 
strongest predictor of management. Increasing age and comorbidities were associated with the 
choice for active surveillance (P=0.000), not performing a lymphadenectomy in patients with 
nodal metastases (RRR:2.5,95%CI:1.4-4.2,P=0.002 and RRR:1.6,95%CI:1.2-2.1,P=0.004, 
respectively) and recommending hemithyroidectomy versus total thyroidectomy for a 
cancer>4cm (RRR:4.4, 95%CI:2.5-7.9,P=0.000 and RRR:3.4,95%CI:2.3-5.1,P=0.000, 
respectively). Surgeons with≥10 years of experience (RRR:3.3,95%CI:1.1-10.3,P=0.039) 
favored total thyroidectomy for a cancer<4cm, and non-fellowship trained surgeons 
(RRR:7.3,95%CI:1.3-42.2,P=0.027) opted for thyroidectomy without lymphadenectomy for 
lateral neck nodal metastases.  
Conclusions: This study highlights the variation in surgical management of older adults with 
thyroid cancer and demonstrates the influence of patient age, comorbidities, surgeon 









The population of older adults in the U.S. is on the rise, with an estimated 58% increase 
in the population aged 65 and older and an 85% increase in the population aged over 85 by the 
year 2035(96). The incidence of thyroid cancer is also increasing across all age groups(97).  
While thyroidectomy remains the gold standard treatment of thyroid cancer, several population-
based studies suggest that an age-related treatment variation may exist. Analysis of patients 
with differentiated thyroid cancer (DTC) in the Surveillance, Epidemiology, and End Results 
(SEER) database from 2004-2015 demonstrated that compared to younger adults, older adults 
(age ≥65) were more likely to undergo active surveillance and had a significantly worse disease-
specific survival. Ho, et al. also found that while active surveillance may be an appropriate and 
safe option for younger adults with DTC, it was associated with significantly worse disease-
specific survival for patients >72 years old(122). Additionally, both of these studies found that 
older adults underwent thyroid lobectomy more frequently compared to the younger cohort(123). 
While these studies demonstrate varying patterns of surgical practice, they do not adequately 
address the decision-making process that led to these findings.  
Older adults pose unique challenges for surgical decision-making, as physicians must 
weigh the risks of surgery against the likelihood of cancer progression, morbidity, and mortality.  
On one hand, the majority of thyroid cancers are small, slow-growing, and low-risk, and despite 
its increasing incidence, mortality from thyroid cancer has remained stable(97, 98). 
Furthermore, recent studies have found that patients pursuing active surveillance for DTC 
≤1.5cm have slow or minimal progression of disease, especially in older adults(124, 125). On 
the other hand, other studies have found that increasing patient age has been associated with 
higher rates of recurrence, worse prognosis, aggressive disease characteristics, lymph node 
(LN) metastasis, and increased mortality(6, 101, 102). While single institution studies cite the 
safety of thyroidectomy in older adults, population-based studies demonstrate an increased rate 
of complications and hospital length of stay compared to younger adults(5, 6, 20). Surgeon 
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preference and experience may also affect surgical recommendations in this patient population. 
It remains unclear how surgeons currently assess older adults and decide upon surgical 
treatment or lack thereof.  
 We therefore developed a survey, in the form of a discrete choice experiment (DCE) to 
understand surgeon preferences for treatment of thyroid cancer in older adults based on patient 
age, functional status, comorbidities, tumor size, and lymph node metastases(105). The primary 
objective of our study was to identify the patient and surgeon characteristics that are most 
influential in surgical decision-making for older patients with differentiated thyroid cancer. 
Methods and Analysis: 
Survey Design 
The Discrete Choice Experiment (DCE) method is a unique quantitative technique used 
in health care research to elicit preferences, priorities, and individual features associated with 
particular services. While these methods have been primarily used to understand patient 
preferences, they have also been applied to study clinical decision-making(106, 109).  DCE 
presents clinical scenarios and forces respondents to make trade-offs among different treatment 
options, providing insight into the relative importance of each characteristic, or attribute, that 
makes up that particular scenario. The range of values that define an attribute are known as 
levels. 
Standard DCE methodology was used to design, implement, and analyze this 
survey(106). After a literature review and key informant interviews with high-volume endocrine 
surgeons and otolaryngologists, attributes, or characteristics, for the clinical scenarios were 
chosen (Table 1). Attributes included age, comorbidities, functional status, tumor size, and 
lateral neck lymph node status. Three overarching clinical scenarios based on extent of disease 
were created: 1) tumor size <4cm, node negative, 2) tumor size <4cm with lateral neck lymph 
node metastasis, and 3) tumor size ≥4cm, node negative.  Tumor size was included to assess 
variation in extent of thyroidectomy (hemithyroidectomy versus total thyroidectomy), and 
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presence of lateral neck lymph node metastasis was utilized to assess whether a lateral neck 
lymph node dissection would be performed. Within each of the three extent of disease 
scenarios, eight patients with varying levels of attributes for age, comorbidities, and functional 
status were created for a total of 24 clinical scenarios (Figure 1). 
In addition to the clinical scenarios, the survey instrument included questions regarding 
surgeon demographics and clinical practice. The survey instrument also included a question 
asking surgeons to select as many options from a list of various methods that they utilized to 
assess younger (<65 years) and older (≥65) adults’ ability to tolerate surgery. This list was 
generated from a literature search and key informant interviews to come up with a list of 
attributes to include in the clinical scenarios. The respondents also chose how important they 
felt that the options they selected were. The survey instrument was extensively piloted to test 
face validity and was iteratively refined.   
Under IRB approval, survey invitations were electronically distributed using the Qualtrics 
XM (SAP, WA, USA) interface to all candidate and active members of the American Association 
of Endocrine Surgeons (AAES) who practice in the United States (n= 404). The link to the 
survey was e-mailed with an introduction regarding its purpose and informed consent, followed 
by three separate reminder e-mails sent 1 week apart.  
Statistical Analysis 
All statistical analyses were performed using STATA version 15 (StataCorp., TX, 
USA). Descriptive statistics were compared using Fisher’s exact test or rank sum, as 
appropriate. Patient scenario attributes were modeled as categorical variables. Five surgeon 
factors were evaluated including surgeon age, annual thyroid surgery volume (low and high 
volume were defined as <25 and ≥25 thyroidectomies, respectively(126)), fellowship training, 
years in practice, and practice limited to endocrine surgery only.  
The association among the treatment choice and patient or surgeon factors for each 
clinical scenario was analyzed using multinomial logistic regression (MNL) with robust variance 
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estimates, clustered by respondent to account for within-respondent variation. Effects coding 
was utilized to structure the data (127). The regression provided relative prevalence ratios, 
which reflect the probability of choosing a particular treatment.  
Results: 
Respondent Characteristics 
Overall survey response rate was 128/404 (31.7%), with 104 (25.7%) members 
completing all portions of the survey (Table 2). Of the 104 that completed the survey, the mean 
age was 46 years old (range 32-71). The majority of the respondents were male (56.7%), white 
(75%), fellowship-trained (83.6%) and high volume thyroid surgeons (88.5%). The median 
number of years in practice was 10 (IQR 5-18.5 years), and 46.2% reported an endocrine 
surgery only practice. The majority of respondents described their practice setting as academic 
with teaching (76.9%), followed by community hospital with an academic affiliation (17.3%), and 
community hospital without teaching (5.8%). Over half (56.3%) reported that 25-50% of the 
thyroid operations they performed in the past two years were on patients ≥65 years old. 
Self-Reported Methods to Assess Older Adults 
When presented with a list of options, surgeons were asked to select methods they used 
and felt were important to evaluate a patient’s ability to tolerate surgery by age group (<65 years 
compared to ≥65 years) (Figure 2). Respondents placed most importance on number and type 
of comorbidities for patients both <65 years of age (92.9%) and ≥65 years (96.1%). For patients 
≥65 years old, subjective assessment of functional status (89.2%), and the “eyeball test” or a 
clinician’s initial intuition of the patient’s health (83.3%), were the next most important methods 
utilized. For patients <65 years old, the frequency of use of the “eyeball test” (80.6%) was 
similar, but estimate of functional status (64.1%) was less commonly used for this age group.  
The least important methods across all age groups were objective measures of 
comorbidity and functional status, with only 1.0% of respondents using a comorbidity index, and 
3.9% and 7.8% of participants reported the calculation of a frailty index for patients <65 and ≥65 
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years of age, respectively. Chronological age was considered important by 25.2%, 35.7%, and 
64.3% in patients <65, 65-79, and ≥80 years old, respectively. Other methods of assessment 
frequently utilized were the assessment of patient comorbidities by other physicians and an 
estimate of life expectancy, with the majority (75.0%) of participants saying that life expectancy 
<3 years would be an indication to not operate. Of the respondents, 69.5% acknowledged the 
existence of guidelines from the American College of Surgeons Coalition on Geriatric Surgery 
for the peri-operative management of older adults, but only 24.4% reported using them(128). 
Association Between Treatment Decisions, Patient Factors, and Surgeon Characteristics 
When presented with three overarching clinical scenarios, MNL demonstrated that age 
was the strongest predictor of management followed by comorbidities regardless of the tumor 
size or extent of disease. Poor functional status was significant in univariable MNL, but was 
omitted in multivariable MNL analysis due to collinearity with co-morbidities.  
For the first clinical scenario, a 2.5-cm, node-negative PTC confined to the thyroid gland, 
significant practice variation existed.  In a 40-year-old, relatively healthy patient, who served as 
a reference patient, 64.6% of respondents chose to perform a total thyroidectomy, 35.4% 
thyroid lobectomy, and none opted for active surveillance, whereas for an 88-year-old patient 
with ≥2 comorbidities, 11.5% chose total thyroidectomy, 17.3% thyroid lobectomy, and 71.2% 
active surveillance. However, 16.3% of respondents chose the same treatment for all patients in 
this scenario regardless of patient presentation, of which most chose hemithyroidectomy. MNL 
demonstrated that patient age (RRR: 3.2x105, 95% CI: 2.2x105-4.5x105, P= 0.000) and 
comorbidities (RRR: 5.8, 95% CI: 4.3-7.9, P= 0.000) were significant independent predictors for 
pursuing active surveillance compared to hemithyroidectomy. When comparing the choice for 
total versus hemithyroidectomy, patient age ≥65 was associated with a lower likelihood of 
recommending a total thyroidectomy (RRR: 0.7, 95% CI: 0.4-1.0, P= 0.041), whereas surgeon 
experience ≥10 years was associated with a higher likelihood (RRR: 3.3, 95% CI: 1.1-10.3, P= 
0.039) (Table 3A).                                                                                                  
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For the second clinical scenario, a 2.5-cm PTC confined to the thyroid gland with lateral 
neck lymph node metastases, significant practice variation was again observed. For the 
reference 40- year-old patient, 88.1% of respondents chose to perform a total thyroidectomy 
with central and lateral neck lymph node dissection (LND), 5.9% hemithyroidectomy with central 
and lateral LND, 6.0% hemi- or total thyroidectomy without lateral neck LND, and 0% opted for 
active surveillance, whereas for an 88-year-old patient with ≥2 comorbidities, 27.7% chose to 
perform a total thyroidectomy with central and lateral neck LND, 7.9% hemithyroidectomy with 
central and lateral neck LND, 10.0% hemi- or total thyroidectomy without lateral neck LND, and 
54.5% opted for active surveillance. Interestingly, 26.7% of respondents chose to perform a total 
thyroidectomy with central and lateral neck LND for all patients in this scenario. When 
comparing the choice for active surveillance to total thyroidectomy with central and lateral LND, 
MNL demonstrated that increasing patient age (RRR: 8.9x105, 95% CI: 5.9x105-1.5x106, P= 
0.000) and ³ 2 comorbidities (RRR: 9.9, 95% CI: 6.6-14.9, P= 0.000) was associated with a 
higher likelihood of active surveillance. Surgical practice dedicated to endocrine surgery only 
was associated with a lower likelihood of pursuing active surveillance (RRR: 0.4, 95% CI: 0.2-
0.9; P= 0.037). Regarding management of the lateral neck lymph node metastases, factors 
associated with surgical management without a lateral neck LND included patient age 
(RRR:2.5, 95% CI: 1.4-4.7, P= 0.002) and comorbidities (RRR:1.6, 95% CI: 1.2-2.1, P= 0.004).  
Non-fellowship trained surgeons were also more likely to forgo lateral neck LND (RRR: 7.3, 95% 
CI: 1.3-42.2 P= 0.027), as were high volume surgeons (RRR: 1.6x107, 95% CI: 6.7x106 -
3.8x107, P= 0.000) (Table 3B).  
For the third clinical scenario, a 4.1-cm, node-negative PTC confined to the thyroid 
gland, variation in treatment choice was seen across age groups. In the 40-year-old reference 
patient, 92.1% of respondents chose to perform a total thyroidectomy, 40.6% with prophylactic 
central LND, 8.0% chose hemithyroidectomy, 5.0% with prophylactic central LND, and 0% opted 
for active surveillance, compared to an 88-year-old patient with ≥2 comorbidities, 35.7% opted 
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for a total thyroidectomy, 11.9% with prophylactic central LND, 25.7% chose 
hemithyroidectomy, 6.9% with prophylactic central LND, and 38.6% opted for active 
surveillance. However, 24.8% of respondents chose the same treatment for all patients, of 
which, 88.8% chose a total thyroidectomy, with 40.7% choosing concomitant central LND. In 
comparing the choice of hemithyroidectomy to total thyroidectomy, multivariable MNL 
demonstrated that patient age (RRR: 4.4, 95% CI: 2.5-7.9, P= 0.000) and comorbidities (RRR: 
3.4, 95% CI: 2.3-5.1, P= 0.000) were significant predictors. Choice for active surveillance was 
also more likely with increasing patient age (RRR: 4.1x105, 95% CI: 2.7x105- 6.3x105, P= 0.000) 
and comorbidities (RRR: 24.5, 95% CI:10.4-57.8, P= 0.000) (Table 3C).  
Discussion: 
This is the first study to utilize the discrete choice experiment (DCE) methodology to 
quantify the impact of key clinical and surgeon factors on the choice of therapy for older adults 
with thyroid cancer and to shed light on reasons for the existence of practice variation.  
Increasing patient age, followed by number of comorbidities, was the strongest predictor of 
management of thyroid cancer in older adults, and increased the likelihood of active surveillance 
across all scenarios. Extent of surgery was also associated with surgeon characteristics 
including ≥10 years of experience, surgical volume, fellowship training, and amount of practice 
dedicated to endocrine surgery. Finally, the preferences elicited from the scenarios identified 
factors deemed important for surgical decision-making, which differed from surgeon-reported 
factors. 
Variation in choice for treatment of thyroid cancer has been well-documented and 
reflected in the clinical practice guidelines by the American Thyroid Association (ATA)(104, 
129). Even though the majority of the participants in our study were high volume, fellowship-
trained endocrine surgeons practicing at academic institutions with at least 10 years of 
experience, significant practice variation existed in the choice of treatment for thyroid cancer, 
especially regarding extent of surgery. Factors that influenced extent of thyroidectomy included 
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tumor size, presence of nodal metastases, patient age and comorbidities, in addition to surgeon 
characteristics. Surgeon experience ≥10 years was associated with a 3.3-fold higher likelihood 
in a tumor <4cm.  Although many recent studies support the safety and adequacy of treatment 
with lobectomy for DTC(6, 130, 131), other studies demonstrate a high incidence of multifocality 
and completion lobectomies(132, 133). This inconsistency in the literature may be reflected in 
our results.  
Factors associated with the choice for active surveillance included increasing patient age 
and comorbidities across all patient scenarios. There is growing evidence supporting active 
surveillance for PTC <1.5cm, with some studies additionally citing a lower risk of growth with 
increasing age(124, 125, 134). However, a recent SEER-based study by Ho, et al. showed that 
disease-specific mortality significantly worsened with patient age >72 years, and also for 
patients with tumors measuring ≥2cm that were not resected(122). Furthermore, although lymph 
node metastases have been associated with higher rates of recurrence and worse disease-
specific survival(104), patient age and comorbidities were associated with opting for non-
surgical management in patients with lateral neck lymph node involvement. It is not known if 
there is a patient life expectancy or other objective measure that corresponds with a survival 
benefit from surgery. This was exhibited in the wide range of answers reported when asked 
what duration of life expectancy would cause respondents to not recommend surgery. 
Treatment variation is not inherently a negative finding, and variation is expected in the setting 
of ongoing research supporting the safety of more conservative treatment strategies in select 
cases. However, it is important to understand the patient and surgeon factors that lead to 
deviation from evidence-based practice, as nonadherence to guidelines has been shown to 
compromise survival(135).   
Not only does the DCE highlight factors important in decision-making, but this method 
has also been proven to determine preferences better than physician self-reflection alone(106). 
Respondents ranked subjective assessment of comorbidities and functional status as the most 
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important methods to assess surgical fitness, yet objective measurements of these factors, 
comorbidity and frailty indices, respectively, were used the least frequently. Additionally, less 
than half reported that chronological age was essential in this decision, despite the influence of 
age demonstrated by MNL. The subjective and wide range of pre-operative assessments 
coupled with treatment variation suggests that incorporating objective assessments specific to 
older adults with thyroid cancer may help to standardize care.   
While surgical decision-making is ultimately a discussion between the patient and 
surgeon, the implementation of an objective surgical risk assessment tool would help to facilitate 
informed shared decisions without subjective biases. Extension of discrete choice experiment 
surveys to other physicians involved in the care of older adults with thyroid cancer, such as a 
broader group of surgeons and endocrinologists, would aid in further characterization of the 
treatment variation seen in large, population-based studies. This would then yield a platform for 
possible intervention. 
There are several limitations of this study. First, stated preferences for choice of therapy 
in thyroid cancer was assessed in an idealized context as opposed to understanding actual 
practice patterns. Real-world scenarios would additionally include information regarding referral 
information, details of past medical history, unique imaging findings, or patient/family desires, 
which alter surgical decision-making.  Referring physicians also play a significant role and may 
impact the choice of therapy. The response rate for completion of the survey was 25.7% for a 
total of 104 respondents, which is low but consistent with other DCE surveys, and non-response 
bias may have influenced our results(105, 106). Furthermore, all participants were endocrine 
surgeons, mostly general surgery-trained, and the majority had high volume practices in an 
academic setting with greater than 10 years of experience, which may limit the generalizability 
of these results as the majority of thyroid surgery is performed by low volume surgeons(126). 
In conclusion, this study highlights the variation in treatment patterns for older adults with 
DTC and the impact of chronological age on the surgical decision-making process. While most 
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survey respondents did not perceive chronological age as an important factor for surgical 
decision-making, MNL analysis found that patient age is the most significant predictor of 
treatment choices, followed by patient comorbidities, while holding tumor size and extent of 
disease constant. Surgeon characteristics such as fellowship training, surgical volume, and 
years of experience also influenced the surgical recommendations delivered. Greater than 10 
years of surgical experience and fellowship training were associated with a higher likelihood of 
performing greater extent of surgery in a patient with lateral neck lymph node metastases. As 
clinical practice guidelines for DTC continue to evolve, it is important to understand the factors 
that affect adherence to or deviation from recommended therapies in order to standardize 
consistent, high-quality treatment. This work encourages the incorporation of risk indices 
dedicated to the treatment of older adults with thyroid cancer, as well as guidelines specific to 
this population to optimize treatment strategies and outcomes.   
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Table 1. Attributes and Levels in Discrete Choice Experiment Clinical Scenarios 
Attributes Levels 




Comorbidities ≤1 Comorbidity 
2-3 Comorbidities 
≥4 Comorbidities 
Functional Status Good  
Poor  
Nodal Status Positive 
Negative 







Table 2. Demographics and Practice Characteristics of Complete Survey Respondents  
 
Characteristic (n = 104) 
Number (%) 
Mean Age (Range) 46 (32-71) 
Gender  
   Male 59 (56.7) 
Fellowship Training  
   Endocrine Surgery  70 (67.3) 
   Surgical Oncology  14 (13.5) 
   Endocrine Surgery and Surgical Oncology 1 (1.0) 
   Otolaryngology, Head and Neck  2 (1.9) 
   None 17 (16.3) 
Percentage of Practice Limited to Endocrine 
Surgery 
 
   100% 48 (46.2) 
   ≥50% 32 (30.8) 
   ≥25% but <50% 17 (16.3) 
 <25% 7 (6.7) 
Years in Practice  
   <5 23 (22.1) 
    5-9 28 (26.9) 
   10-19 28 (26.9) 
   ≥20 25 (24.0) 
Annual Volume of Thyroid Surgeries  
   High (>25) 92 (88.5) 
Practice Setting  
   Academic with Teaching 80 (76.9) 
   Community with Academic Affiliation 18 (17.3) 





Table 3A. Node Negative PTC <4cm: Patient and Surgical Determinants of Choice for 
Total Thyroidectomy or Active Surveillance Compared to Thyroid Lobectomy. 
 
Characteristic Total Thyroidectomy vs. 
Thyroid Lobectomy (Ref) 
Active Surveillance vs. Thyroid 
Lobectomy (Ref) 
 RRR 95% CI P Value RRR 95% CI P value 
Patient Attributes      
  Age       
   <55 Years Ref   Ref   
   55-64 Years 1.1 0.9-1.3 0.35 27.4* 19.9-37.5 0.000 
Age ≥65  0.7* 0.4-1.0 0.041 1.2x104* 8.0x103-
1.7x104 
0.000 
   65-79 Years 1.0 0.8-1.2 0.92 39.0* 30.3-50.2 0.000 
   ≥80 Years 0.6* 0.4-0.9 0.03 296.2* 222.8-
393.8 
0.000 
Comorbidities       
   ≤ 1  Ref   Ref   
≥2 Comorbidities 0.9 0.7-1.1 0.286 5.8* 4.3-7.9 0.000 
   2-3  0.9 0.7-1.1 0.375 1.8* 1.4-2.3 0.000 
   ≥4 0.9 0.7-1.2 0.626 3.6* 2.6-5.0 0.000 
Surgeon Characteristics      
Age 1.0 0.9-1.0 0.179 1.0 0.9-1.0 0.365 
Years in Practice       
   < 10 Ref   Ref   
   ≥10 3.3* 1.1-10.3 0.039 2.4 0.9-5.6 0.079 
Fellowship Training      
    Yes Ref   Ref   
    No 1.5 0.5-4.8 0.462 0.5 0.2-1.3 0.140 
Endocrine Surgery Only Practice     
   Yes Ref   Ref   
   No 1.3 0.6-2.7 0.513 0.8 0.4-1.5 0.421 
Annual Volume       
   Low Ref   Ref   
   High 0.3 0.04-1.5 0.131 0.9 0.3-2.3 0.746 
Ref= Reference 
RRR= Relative Risk Ratio 
CI= Confidence Interval 
Functional status omitted due to co-linearity with co-morbidities 




Table 3B. Node Positive PTC <4cm: Patient and Surgical Determinants of Choice for 
Management of Lateral Neck Lymph Node Metastasis and Choice for Active Surveillance 
compared to Total Thyroidectomy with Central & Lateral Neck Dissection. 
 
Characteristic -Lymphadenectomy vs. 
+Lymphadenectomy (Ref) 
Active Surveillance vs. Total 
Thyroidectomy with Central & 
Lateral Neck Dissection (Ref) 
 RRR 95% CI P value RRR 95% CI P value 
Patient Attributes       
 Age       
   <55 Years Ref   Ref   
   55-64 Years 1.0 0.8-1.2 0.991 29.3* 20.9-41.2 0.000 
Age ≥65  2.5* 1.5-4.4 0.001 3.0x104* 2.1x104-
4.5x104 
0.000 
   65-79 Years 1.2 0.9-1.5 0.144 72.7* 56.9-92.9 0.000 
   ≥80 Years 2.1* 1.4-3.3 0.000 419.1* 299.8-
585.9 
0.000 
Comorbidities       
   0-1  Ref   Ref   
≥2 Comorbidities 1.6* 1.2-2.1 0.004 9.9* 6.6-14.9 0.000 
      2-3  1.2 0.9-1.6 0.264 2.9* 2.1-4.1 0.000 
      ≥4 1.3 1.0-1.9 0.093 3.4* 2.5-4.7 0.000 
Surgeon Characteristics      
Age 1.0 0.9-1.1 0.866 1.0 0.9-1.0 0.386 
Years in Practice       
   <10  Ref   Ref   
   ≥10  0.3 0.1-1.8 0.195 3.0 1.0-9.0 0.052 
Fellowship Training      
    Yes Ref   Ref   
    No 7.3* 1.3-42.2 0.027 0.7 0.2-2.1 0.489 
Endocrine Surgery Only Practice     
   Yes Ref   Ref   
   No 0.3 0.1-1.0 0.053 0.4* 0.2-0.9 0.037 
Annual Volume       
   Low Ref   Ref   
   High 1.6x107* 6.7x106-
3.8x107 
0.000 1.4 0.3-6.5 0.634 
Ref= Reference 
RRR= Relative Risk Ratio 
CI= Confidence Interval 
Functional status omitted due to co-linearity with co-morbidities 
*All P values set for significance <0.05  
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Table 3C. Node Negative PTC >4 cm: Patient and Surgical Determinants of Choice for 
Thyroid Lobectomy or Active Surveillance Compared to Total Thyroidectomy.  
 
Characteristic Thyroid Lobectomy vs. Total 
Thyroidectomy (Ref) 
Active Surveillance vs. Total 
Thyroidectomy (Ref) 
 RRR 95% CI P value RRR 95% CI P value 
Patient Attributes      
Patient Age       
   <55 Years Ref   Ref   
   55-64 Years 0.8 0.6-1.1 0.147 10.5* 5.6-19.9 0.000 
Age ≥65 5.4* 3.1-9.7 0.000 3.8x104* 2.2x104-
6.8x104 
0.000 
   65-79 Years 1.2 1.0-1.6 0.090 32.8* 22.2-48.5 0.000 
   ≥80 Years 4.3* 2.7-6.9 0.000 1191.3* 623.0-
2278.3 
0.000 
Comorbidities       
   0-1  Ref   Ref   
≥2 Comorbidities 3.4* 2.3-5.1 0.000 24.5* 10.4-57.8 0.000 
   2-3 1.6 1.3-1.9 0.144 4.2* 2.8-6.2 0.000 
   ≥4 2.0* 1.6-2.7 0.000 6.7* 3.8-11.9 0.000 
Surgeon Characteristics      
Age 1.0 0.9-1.1 0.884 1.0 0.9-1.1 0.882 
Years in Practice       
   <10  Ref    Ref    
   ≥10  1.0 0.3-3.3 0.961 1.7 0.5-5.5 0.407 
Fellowship Training      
    Yes Ref    Ref    
    No 1.4 10.5-4.3 0.535 0.8 0.2-2.7 0.683 
Endocrine Surgery Only Practice     
   Yes Ref   Ref   
   No 1.5 0.7-3.3 0.300 0.7 0.3-1.7 0.468 
Annual Volume       
   Low Ref   Ref   
   High 0.6 0.2-2.2 0.462 2.2 0.3-15.3 0.430 
Ref= Reference 
RRR= Relative Risk Ratio 
CI= Confidence Interval 
Functional status omitted due to co-linearity with co-morbidities 
























Figure 3. Treatment variation for adults with papillary thyroid cancer (PTC) in 3 




















CHAPTER 6.  
Conclusions 
 From our longitudinal prospective cohort study, we found a high prevalence of voice and 
swallowing impairments in older patients pre-operatively as evidence by 67.9% of patients 
having abnormal VHI scores and 77.4% having abnormal DHI. Compared to the pre-operative 
time point, early post-thyroidectomy, almost half of the patients in this cohort had higher VHI 
scores and this persisted up to 6 months in almost 1/3 of patients. Compared to pre-operative 
assessment, post-thyroidectomy 41.5% of patients reported worse swallowing at the initial post-
operative visit and this persisted in 32.1% at 6 months. 
 When evaluating risk factors for voice changes, on unadjusted analyses, frailty was 
associated with adverse voice and swallowing outcomes, which affected quality of life. Frailty 
was specifically associated with adverse outcomes in the functional and physical subscales of 
voice in the early post-operative period. BMI was also associated with adverse functional voice 
outcomes in the early post-operative period. Frailty was also associated with adverse functional 
dysphagia outcomes in the early post-operative period. Functional voice outcomes affect 
activities of daily living.  
 From our study of eliciting how surgeons assess older adults for surgery, the most 
commonly used method was the eyeball test or clinical intuition about the patient. From 
responses to our survey questions, multinomial logistic regression demonstrated that patient 
age was the strongest predictor for extent of surgery or lack thereof.  
Increasing age and comorbidities were associated with the choice for active surveillance of a 
thyroid cancer cancer <4cm, not performing a lymphadenectomy in patients with nodal 
metastases, and recommending hemithyroidectomy versus total thyroidectomy for a 
cancer>4cm. Surgeons with≥10 years of experience favored total thyroidectomy for a 
cancer<4cm, and non-fellowship trained surgeons opted for thyroidectomy without 
lymphadenectomy for lateral neck nodal metastases.   
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 Our final study highlights the variation in treatment patterns for older adults with DTC 
and the impact of chronological age on the surgical decision-making process. While most 
survey respondents did not perceive chronological age as an important factor for surgical 
decision-making, MNL analysis found that patient age is the most significant predictor of 
treatment choices, followed by patient comorbidities, while holding tumor size and extent of 
disease constant. Surgeon characteristics such as fellowship training, surgical volume, and 
years of experience also influenced the surgical recommendations delivered. Greater than 10 
years of surgical experience and fellowship training were associated with a higher likelihood of 
performing greater extent of surgery in a patient with lateral neck lymph node metastases. As 
clinical practice guidelines for DTC continue to evolve, it is important to understand the factors 
that affect adherence to or deviation from recommended therapies in order to standardize 
consistent, high-quality treatment. This work encourages the incorporation of risk indices 
dedicated to the treatment of older adults with thyroid cancer, as well as guidelines specific to 
this population to optimize treatment strategies and outcomes.  
Overall our work highlights the treatment variation in surgical recommendations, lack of 
consistency in evaluation of older patients in need of thyroidectomy, and suggests that frailty, a 
measure of physiologic age, may better reflect how well patients will tolerate surgery. Prior 
studies have demonstrated varying surgical recommendation for thyroid cancer (129, 136, 137). 
These studies have demonstrated variation in rates of hemithyroidectomy versus total 
thyroidectomy, the role of central neck dissection, thyroid hormone management after surgery, 
and radioactive iodine use. Our work is unique in that it provides insight into how surgeons 
place emphasis on certain factors to provide recommendations, the variation on those factors, in 
addition to the lack of objective measures utilized for decision-making.  
Our work also highlights the need for a measure of physiologic reserve, not just to aid in 
decision-making, but to also assess outcomes. Voice and swallowing impairments post-
thyroidectomy are infrequently related to nerve injury, however, they have a significant impact 
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on a patient’s quality of life. Identifying patients at risk for these adverse outcomes will aid in 
early or even pre-operative referral to voice or swallowing rehabilitation. Significant work still 
needs to be done on a larger scale to assess the frailty phenotype as a measure of physiologic 
age to predict voice and swallowing changes after thyroidectomy especially as older patients 
are living longer. There is also significant work that needs to be done to convey the concept of 
physiologic age as opposed to chronologic age to the multitude of surgeons performing 
thyroidectomy procedures and the referring endocrinologists. Additionally, once at risk patients 









































































































































































































































































































































































































































































































































































































Thyroid Cancer in Older Adults - AAES 
 
 
Start of Block: Demographics 
 
Q36 Instructions: We are interested in learning about the thought processes and experiences of 
surgeons involved in deciding upon and performing thyroid surgery in older adults with thyroid 
cancer. There are 3 sections in this survey. In this first set of 10 questions we would like to learn 




Q1 Q1. What gender do you identify as? 
o Male  (1)  
o Female  (2)  









Q3 Q3. Are you of Hispanic, Latino, or Spanish origin or descent?  
o Yes  (1)  






Q4 Q4. Which of the following categories best describes your race? Please choose all that 
apply 
▢ American Indian or Alaskan Native  (1)  
▢ Asian  (2)  
▢ Black or African American  (3)  
▢ Native Hawaiian or Other Pacific Islander  (4)  
▢ White  (5)  
▢ Other  (6)  
 
 
Display This Question: 
If Q4. Which of the following categories best describes your race? Please choose all that apply = Other 
 







Q6 Q5. Please indicate your specialty 
o General Surgery (no fellowship training after residency)  (1)  
o General Surgery and Endocrine Surgery Fellowship  (2)  
o General Surgery and Surgical Oncology Fellowship  (3)  
o Otolaryngology (no fellowship training after residency)  (4)  
o Otolaryngology and Head & Neck/Endocrine Fellowship training  (5)  
o Other  (6)  
 
 
Display This Question: 
If Q5. Please indicate your specialty = Other 
 





Q8 Q6. Please indicate your number of years in practice following completion of training 





Q9 Q7. Thinking about the past two years, please indicate the approximate percentage of 
patients that you have operated on that are over the age of 65. 
o < 10%  (1)  
o ≥10% but   (2)  
o ≥25% but   (3)  






Q10 Q8. Thinking about the past two years, is your practice limited to Endocrine Surgery only?  
o Yes  (1)  
o No  (2)  
 
 
Display This Question: 
If Q8. Thinking about the past two years, is your practice limited to Endocrine Surgery only?  = No 
 
Q11 Please indicate what percentage of your practice is limited to Endocrine Surgery (thyroid, 
parathyroid, adrenal, neuroendocrine) 
o < 10%  (1)  
o ≥10% but   (2)  
o ≥25% but   (3)  




Q12 Q9. Thinking about the past two years, please indicate the approximate number of thyroid 







Q13 Q10. Please select the type of hospital setting at which you primarily practice. 
o Community  (1)  
o Community with an academic affiliation  (2)  
o Academic with teaching  (3)  
o Outpatient surgery only  (4)  
o Other  (5)  
 
 
Display This Question: 
If Q10. Please select the type of hospital setting at which you primarily practice. = Other 
 
Q14 Please specify 
________________________________________________________________ 
 
End of Block: Demographics 
 
Start of Block: Block 1 
 
Q37 In this second set of 6 questions we would like to learn about how you assess a patient’s 







Q15 Q1. Which of the following methods do you typically use to assess the ability of a patient 
age less than 65 years to undergo thyroidectomy. Please choose all that apply 
▢ Overall clinical intuition about the patient when you first meet them (Eyeball 
test)  (1)  
▢ Chronological age  (2)  
▢ Number or type of co-morbidites  (3)  
▢ Estimate of functional status  (4)  
▢ Estimate of life expectancy  (13)  
▢ Calculate a co-morbidity index (Charlson, Elixhauser)  (5)  
▢ Calculate a frailty index  (6)  
▢ Number of medications  (7)  
▢ Anesthesia consult  (8)  
▢ Assessment by other providers based on co-morbidities- cardiologist, internist, 
pulmonologist, etc.  (9)  
▢ Presentation at tumor board  (10)  
▢ Opinion on a social media platform (facebook, ACS community board, etc.)  (11)  






Q16 Q2. Which of the following methods do you typically use to assess the ability of a patient 
age greater than 65 years to undergo thyroidectomy. Please choose all that apply 
▢ Overall clinical intuition about the patient when you first meet them (Eyeball 
test)  (1)  
▢ Chronological age  (2)  
▢ Number or type of co-morbidites  (3)  
▢ Estimate of functional status  (4)  
▢ Estimate of life expectancy  (5)  
▢ Calculate a co-morbidity index (Charlson, Elixhauser)  (6)  
▢ Calculate a frailty index  (7)  
▢ Number of medications  (8)  
▢ Anesthesia consult  (9)  
▢ Assessment by other providers based on co-morbidities- cardiologist, internist, 
pulmonologist, etc.  (10)  
▢ Refer to or have assessed by a geriatrician  (11)  
▢ Presentation at tumor board  (12)  
▢ Opinion on a social medial platform (facebook, ACS community board, etc.)  (13)  





Carry Forward Selected Choices from "Q2. Which of the following methods do you typically use to assess the ability 





Q41 Q3. Of the following methods that you selected, how important are those items when you 
assess a patient's (age 65-79) ability to benefit from surgery?   
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the patient when 
you first meet 
them (Eyeball 
test) (x1)  
o  o  o  o  
Chronological age 
(x2)  o  o  o  o  
Number or type of 
co-morbidites (x3)  o  o  o  o  
Estimate of 
functional status 
(x4)  o  o  o  o  
Estimate of life 




Elixhauser) (x6)  
o  o  o  o  
Calculate a frailty 
index (x7)  o  o  o  o  
Number of 
medications (x8)  o  o  o  o  
Anesthesia 








etc. (x10)  
o  o  o  o  
Refer to or have 
assessed by a 




tumor board (x12)  o  o  o  o  





etc.) (x13)  
o  o  o  o  
None of the above 




Carry Forward Selected Choices from "Q2. Which of the following methods do you typically use to assess the ability 





Q42 Q4. Of the following methods that you selected, how important are those items when you 
assess a  ≥ 80 year old patient's ability to benefit from surgery?   
103 
 









the patient when 
you first meet 
them (Eyeball 
test) (x1)  
o  o  o  o  
Chronological age 
(x2)  o  o  o  o  
Number or type of 
co-morbidites (x3)  o  o  o  o  
Estimate of 
functional status 
(x4)  o  o  o  o  
Estimate of life 




Elixhauser) (x6)  
o  o  o  o  
Calculate a frailty 
index (x7)  o  o  o  o  
Number of 
medications (x8)  o  o  o  o  
Anesthesia 








etc. (x10)  
o  o  o  o  
Refer to or have 
assessed by a 




tumor board (x12)  o  o  o  o  





etc.) (x13)  
o  o  o  o  
None of the above 




Display This Question: 
If Q1. Which of the following methods do you typically use to assess the ability of a patient age le... = Estimate 
of life expectancy 
Or Q2. Which of the following methods do you typically use to assess the ability of a patient age gr... = 
Estimate of life expectancy 
 
Q45 Q5. Please choose how many years at minimum that you consider to be a limited life 
expectancy AND therefore would not recommend any surgical intervention for an adult with 
thyroid cancer? 
o Life expectancy less than 1 year  (1)  
o Life expectancy less than 3 years  (2)  
o Life expectancy less than 5 years  (3)  
o Life expectancy less than 10 years  (4)  
o other  (5)  
 
 
Display This Question: 





Q46 Please specify the number of years, at minimum, that you consider to be a limited life 







Q20 Q6. How often do you weigh the following considerations prior to providing a surgical 
opinion in a patient age > 65 with thyroid pathology 
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 Always (1) Most of the time (2) 
About half the 
time (3) Sometimes (4) Never (5) 
Most thyroid 





untreated (1)  
o  o  o  o  o  
Thyroid cancer 
in older adults 
tends to be 
more 
aggressive (2)  
o  o  o  o  o  
Estimate of 
life-






cancer (4)  
o  o  o  o  o  
Location of 
thyroid cancer 
(5)  o  o  o  o  o  
Risk of 




quality of life 
versus life-
expectancy (7)  











not the patient 
is on synthroid 
(9)  
o  o  o  o  o  
 
 
End of Block: Block 1 
 
Start of Block: Block 3 
 
Q38 Instructions: The following questions present 3 case scenarios in several different patients. 




Q48 A male presents with 2.5 cm palpable, mobile, right-sided PTC with no compressive 
symptoms.  No suspicious lymph nodes are seen on ultrasound. He is euthyroid and has no 
family history of thyroid cancer or prior exposure to XRT.  What would you recommend for each 
of the following patients? 
 Management Options 
 Right thyroid lobectomy (1) Total thyroidectomy (2) Active Surveillance (3) 
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40 year old with 
diabetes, COPD, and 
hypertension. He lives 
alone and takes care of 
himself. (1)  
o  o  o  
58 year old healthy 
male (2)  o  o  o  
74 year old with 
diabetes only. He lives 
alone and takes care of 
himself. (3)  
o  o  o  
92 year old with 
diabetes only. He lives 
alone and takes care of 
himself. (4)  
o  o  o  
60 year old with 
diabetes, hypertension 
s/p cardiac stent two 
years ago. He has lost 
10 pounds in the past 
six months, reports 
poor energy, and 
therefore does not get 
out much. (7)  
o  o  o  
75 year old with COPD 
and diabetes. He 
reports poor energy 
and uses a walker for 
assistance. (5)  
o  o  o  
88 year old with 
hypertension and 
diabetes. He has lost 
10 pounds in the past 
six months, reports 
poor energy, and 
therefore does not get 
out much. He walks 
with assistance. (6)  
o  o  o  
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74 year old with 
hypertension, COPD, 
diabetes, congestive 
heart failure, and 
peripheral vascular 
disease s/p iliac artery 
stent. He lives alone 
and takes care of 
himself (8)  





Q29 A female has a 2.5cm palpable, mobile, right-sided PTC with no compressive symptoms. 
She has a 2cm right lateral (level III) neck node that also demonstrates PTC on biopsy. She is 

































She lives alone 
and takes care 
of herself. (1)  
o  o  o  o  o  
59 year old 
healthy female 
(11)  o  o  o  o  o  
75 year old 
with diabetes 
only. She lives 
alone and 
takes care of 
herself. (2)  
o  o  o  o  o  
89 year old 
with diabetes 
only. She lives 
alone and 
takes care of 
herself. (3)  
o  o  o  o  o  





years ago. She 
has lost 10 






not get out 
much. (9)  
o  o  o  o  o  
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years ago. She 
has lost 10 






not get out 
much. (4)  
o  o  o  o  o  




She has lost 10 






not get out 
much. She 
walks with 
assistance. (5)  
o  o  o  o  o  











stent. She lives 
alone and 
takes care of 
herself (6)  







Q47 A female has a 4.1 cm palpable, mobile, right-sided PTC with no compressive 
symptoms. No suspicious lymph nodes are seen on ultrasound. She is euthyroid and has no 
family history of thyroid cancer or prior exposure to XRT.  
 Management 























She lives alone 
and takes care 
of herself. (1)  
o  o  o  o  o  
75 year old 
with diabetes 
only. She lives 
alone and 
takes care of 
herself. (2)  
o  o  o  o  o  
89 year old 
with diabetes 
only. She lives 
alone and 
takes care of 
herself. (3)  
o  o  o  o  o  





years ago. She 
has lost 10 






not get out 
much. (4)  
o  o  o  o  o  
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years ago. She 
has lost 10 






not get out 
much. (5)  
o  o  o  o  o  
88 year old 
with 
hypertension. 
She has lost 10 






not get out 
much. She 
walks with 
assistance. (6)  
o  o  o  o  o  










lives alone and 
takes care of 
herself. (9)  
o  o  o  o  o  
 
 




Start of Block: Block 2 
 
Q25 Prior to taking this survey, were you aware that the American College of Surgeons has a 
coalition on geriatric surgery?  
o yes  (1)  
o No  (2)  
 
 
Display This Question: 
If Prior to taking this survey, were you aware that the American College of Surgeons has a coalition... = yes 
 
Q26 Prior to taking this survey, were you aware that this organization published best practice 
guidelines regarding optimal pre-operative assessment of the geriatric surgical patient? 
o Yes  (1)  
o No  (2)  
 
 
Display This Question: 
If Prior to taking this survey, were you aware that this organization published best practice guidel... = Yes 
 
Q27 Do you routinely use this guideline in assessment of a geriatric surgical patient? 
o Yes  (1)  




Q43 This now concludes the survey. Thank you for your participation. If you wish to be included 
in a raffle for an Amazon Gift Card, please enter your email address below. It will be separated 
from your survey responses to maintain anonymity.  
________________________________________________________________ 
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Randolph, Editor, Surgery of the Thyroid and Parathyroid Glands. Elsevier, New York, 2019;  I 










EXTRAMURAL Funding  
Research Extramural Funding - Current 
4/1/2017 – 4/1/2022 Association between Frailty and Post-thyroidectomy Alterations in Voice, 
Swallowing, and Quality of Life. 
 1K23AG053429-01A1 
NIA/NIH K23 Mentored Career Development Award 
$847,445 
Role: PI, 75%  
 
Research Extramural Funding – Pending 
7/1/2021 – 06/30/2026  D.E.C.I.D.E (DEcision-making mitigating Cognitive decline and Incident 
DEmentia) in Older 






9/1/2021-8/31/2026 Optimizing Cardiovascular Health in End-Stage Renal Disease Patients with 
Secondary 
   Hyperparathyroidism 
   R01HL000000 
   NHLBI/NIA R01 
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   $3,828,894 
   Role: PI 
 
Research Extramural Funding –  Previous 
8/1/2015-1/31/2018 Frailty and alterations in voice and swallowing after thyroidectomy 
   In older adults and the ability of frailty to predict these  
   Alterations 
Older American Independence Center Pilot/Exploratory Studies  
   Core Award 
   Claude. D. Pepper Center (NIA) 
   $26,500 
   Role: PI 
 
 
INTRAMURAL Funding  
 
Research Intramural Funding – Current 
1/1/2021-12/31/2021 Frailty and shared decision-making in older adults with thyroid cancer 
   Atterbury Discovery Grant 
   Johns Hopkins Thyroid Tumor Center 
   $30,000 
   Role: PI 
 
Research Intramural Funding – Pending 
None 
 
Research Intramural Funding - Previous 
1/1/2016-1/1/2017 Outcomes after thyroidectomy in older adults  
Rothman Pilot Career Development Award 
   Johns Hopkins University School of Medicine Dept of Surgery, 
   $25,000 
   Role: PI, 10% 
 
1/1/2016-1/1/2018 Association between frailty and outcomes after thyroidectomy in 
   Older adults 
The Johns Hopkins Clinician-Scientist Award 
   $80,000 
   Role: PI, 75% 
 
4/1/2016-12/31/2016 Outcomes in thyroidectomy in older adults vs. younger adults  
Premier Healthcare Database 
   $10,000 





Clinical Focus  
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As a fellowship trained endocrine surgeon, my primary focus is on surgical management of thyroid, 
parathyroid, and adrenal disease.  In addition to my clinical activities at JHH Baltimore, I have developed 
a tertiary care endocrine surgery presence in the National Capitol Region, drawing patients from 
Maryland, Washington DC, Delaware, and Virginia.   I continue to be an active member of the Thyroid 
Tumor Center and the Adrenal Tumor Center at Johns Hopkins. Starting in March 2021, I will be Co-





Medical, other state/government licensure  
8/2014-present State of Maryland Medical License (# D0078322); renewed 2016; 2018; 2020 
  
6/2007-present District of Columbia Medical License (# MD036712) renewed every 2 years since 
 
Boards, other specialty certification  
2014-present Board Certified, American Board of Surgery #059069 
 
Clinical (Service) Responsibilities 
2014-present  Faculty, Endocrine Surgery. Clinical activity 1.5 days/week 
2017-present Director, Endocrine Surgery Fellowship Program 
 
Clinical Productivity 
2017-present My targeted clinical effort assignment is 25%. My wRVU target is 2150 and I have 
consistently 
met or exceeded this target.  
 
Clinical Draw from outside local/regional area  
2014-present 20% of my patients  came from other states such as DE, DC, FL, NY,OH, PA, SC, TN, VA, 
WV WV 
  International patients came from other countries such as Nigeria, Haiti, Bermuda, 
Middle East, 
Honduras, and Pakistan.  
 
Membership in or examiner for specialty board 
None 
 
Clinical Program Building / Leadership 
2016- present Johns Hopkins Endocrine Surgery in the National Capitol Region at Sibley 
Memorial Hospital.  I helped expand the JHUSOM Endocrine Surgery footprint to 
the NCR at Sibley.  I helped to setup the endocrine surgery outpatient clinic 
including instrumentation and the operating rooms.   
 
Clinical Demonstration Activities  
None 
 





EDUCATIONAL ACTIVITIES  
Educational Focus  
My educational focus has centered around surgical management of thyroid, parathyroid, or adrenal 
disease. My target audiences are medical students, residents, and fellows by providing instruction in the 
operating room, clinics,  classroom and anatomy labs. These activities include: 
 -Teaching thyroid and lateral Neck Anatomy (via cadavaeric dissection labs) to Residents 
-Teaching residents and fellows (Endocrine and Surgical Oncology) surgical management of 
thyroid, adrenal, 
and parathyroid disorders via lectures 
- Friday morning Resident and Fellow Endocrine Surgery conference 
 - Resident and Surgical Oncology Fellow Oral Board Exam Preparation 
 - Medical student tumor board 
 - Medical student Professors Hours 
 - CME Instruction  
 - Capstone project mentor for MPH students at Johns Hopkins School of Public Health 
 - Faculty advisor for medical students 
 - Johns Hopkins Medical School Admissions Committee 
  
Teaching    
Classroom instruction   
JHMI/Regional 
2014-present Facilitator for 3rd year medical students on surgery clerkship, Medical Student Tumor 
Board that 
   convenes every other month 
2014-present Facilitator, weekly endocrine surgery conference for fellows, residents, and students on  
   endocrine surgery service 
2/5/2015 Educator; Resident cadaveric labs: head and neck dissection   
2/11/2015 Resident Lecturer; Parotidectomy, Neck Dissection; Thyroid and Parathyroid Disease 
2/19/2015 Resident Lecturer; Adrenal masses and adrenalectomy 
2/26/2015 Educator; Resident cadaveric labs: head and neck dissection 
11/19/2015 Resident Lecturer; Head and Neck Diagnosis, Oral cavity lesions, and neck masses 
2/4/2016 Resident Lecturer; Adrenal masses and adrenalectomy 
9/8/2016 Substitute Educator – Clinical Foundations Medicine Course SOM, 1st   
   year medical student 
10/13/2016 Resident Lecturer; Endocrine problems and work up 
10/27/2016 Resident Lecturer; Endocrine problems and work up 
12/15/2016 Educator; Resident cadaveric labs: head and neck dissection 
11/2/2017 Resident Lecturer; Endocrine problems and work up 
11/16/2017 Resident Lecturer; Neck masses 
6/20/2018 Professors Hour with medical students 
6/20/2018 Mock Interview night with medical students 
9/26/2018 Facilitator, Medical Student Tumor board (3rd year medical students) 
10/11/2018 Resident Lecturer; Endocrine Problems and work up Part 1 
10/11/2018   The Johns Hopkins University Interprofessional Education and Interprofessional Clinical 
Practice: SOM, SON, and Norte Dame of Maryland School of Pharmacy (SOP) 
Selected SOM Faculty Mentor, IPE Event #1: Values and Ethics for Interprofessional 
Practice Curriculum, first year pre-licensure medical, nursing, and pharmacy learners 
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(~200 students) from JH School of Medicine, JH School of Nursing and the Notre Dame 
of Maryland University School of Pharmacy are required to participate in four IPE events 
during their studies as part of a graduation requirement from each of the respective 
programs.  
10/18/2018 Resident Lecturer; Endocrine Problems and work up Part II 
10/3/2019 Resident Lecturer; Thyroid 
10/10/2019 The Johns Hopkins University Interprofessional Education and Interprofessional Clinical 
Practice: SOM, SON, and Norte Dame of Maryland School of Pharmacy (SOP) 
Selected SOM Faculty Mentor, IPE Event #1: Values and Ethics for Interprofessional 
Practice Curriculum, first year pre-licensure medical, nursing, and pharmacy learners 
(~200 students) from JH School of Medicine, JH School of Nursing and the Notre Dame 
of Maryland University School of Pharmacy are required to participate in four IPE events 
during their studies as part of a graduation requirement from each of the respective 
programs.  
1/21/2020 The Johns Hopkins University Interprofessional Education and Interprofessional Clinical 
Practice: SOM, SON, and Norte Dame of Maryland School of Pharmacy (SOP) 
Selected SOM Faculty Mentor, IPE Event #3: Values and Ethics for Interprofessional 
Practice Curriculum, first year pre-licensure medical, nursing, and pharmacy learners 
(~200 students) from JH School of Medicine, JH School of Nursing and the Notre Dame 
of Maryland University School of Pharmacy are required to participate in four IPE events 
during their studies as part of a graduation requirement from each of the respective 
programs.  
 
10/21/2020 IPE Events Values and Ethics for Interprofessional Practice 
§ Professionalism for Nursing in Health Care: With Hopkins Nursing Seminar-
Ethics and Cultural 
• Humility (SON: 120.501) 
§ SOM requirement 
§ SOP requirement 
 
2/2/2021 Surgical Oncology Fellow Mock Oral Boards 
 
2/9/2021 IPE Event#4 Values and Ethics for Interprofessional Practice: Communication and 
Teamwork 
§ Professionalism for Nursing in Health Care: With Hopkins Nursing Seminar-
Ethics and Cultural 
• Humility (SON: 120.501) 
§ SOM requirement 
§ SOP requirement 
 










Clinical instruction  
JHMI/Regional 







10/2/2015 Speaker, “Medullary Thyroid Cancer,” and Panelist “Management of the Thyroid 
Nodule” Contemporary Surgical Management of Thyroid and Parathyroid Disease, The 
Johns Hopkins 
Hospital  
11/18/2016 Speaker, “Medullary Thyroid Cancer,” and Panelist “Management of the Thyroid 
Nodule” Contemporary Surgical Management of Thyroid and Parathyroid Disease, The 
Johns Hopkins 
Hospital 
11/17/2017 Speaker, “Medullary Thyroid Cancer,” and Panelist “Management of the Thyroid 
Nodule” Contemporary Surgical Management of Thyroid and Parathyroid Disease, The 
Johns Hopkins 
Hospital  
11/9/2018 Speaker, “Medullary Thyroid Cancer,” and Panelist “Management of the Thyroid 
Nodule” Contemporary Surgical Management of Thyroid and Parathyroid Disease, The 
Johns Hopkins 
Hospital 
6/19/2019 Speaker, “Surgical Approaches to Adrenal Disease” Inaugural Case Based Issues in 
Adrenal Disorders: Case-based Management, The Johns Hopkins Hospital 
11/22/2019 Speaker, “Medullary Thyroid Cancer,” and Panelist “Management of the Thyroid 







Workshops /seminars  
JHMI/Regional None 
National   None 
International   None 
 
Mentoring  
Pre-doctoral Advisees /Mentees  
2017- 2019 Lindsay Dickerson, medical student, now a general surgery resident at University of 
Washington 
2017- 2019 Sophie Lin, medical student, now in residency   
2017 – 2018 Fadi Murad 
MPH student for Capstone Project 
Mentor on poster 10/18 
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2016-2017 Ghedak Ansari 
MPH student for Capstone Project 
 Mentor on publication OR[22] 
2016-2017 Ashwyn Sharma, medical student 
Current Surgical Resident at UCSD 
 Mentor on publication CR[2] 
2014- 2016 Neeraja Nagarajan, MD MPH 
  Presently working at McKinsey Consulting  
  Mentored publication OR [18] 
 
Post-doctoral Advisees /Mentees  
2020-Present Shkala Karzai, MD 
  Endocrine Surgery Fellow 
  Mentor on OR [36,37] 
 
2019-Present Whitney Sutton, MD 
  General Surgery Resident 
  Mentor on OR [29-31, 35-37] and Poster 10/19 
 
2018–2019 Jessica B. Shank, MD 
  Endocrine Surgery Fellow 
  Mentor on publication RA[5] and poster 8/19 
 
2018-2019 Sandra DiBrito, MD 
  General Surgery Resident 
  Mentor on publication OR[28] 
 
2017-2018 Said Azoury, MD 
  General Surgery Resident 
  Mentored publication BC[7] 
 
2016-2018 Zeyad Sahli, MD 
Presently general surgery resident at UVA 
Received American Thyroid Association trainee grant 
Mentored publications OR[19-24,33,34] and  CR[1] 
 
2014-2015 Stacie Kahan, MD 
  Endocrine Surgery Fellow 
  Mentored publication OR[18] 
   
 
Thesis committees  
None 
 
Educational Program Building / Leadership  




In my capacity, I am responsible for the oversight and training experience that fulfills the 
requirements of the accrediting society to one Endocrine Surgery Fellow per year. I also 
maintain accreditation for our fellowship program.  
 





Research Focus  
I am a board-certified general surgeon and a fellowship-trained endocrine surgeon with multiple years 
of research experience beginning at the National Cancer Institute.  My previous and current research 
has focused on improving the care and outcomes of patients with diseases of the thyroid, parathyroid, 
and adrenal glands.  My current focus is on understanding outcomes in older adults. I am also obtaining 
advanced training at the Bloomberg School of Public Health to better position myself to perform high 
quality research.  Ultimately, I hope to become an independent R01 funded investigator and leader in 
the field of endocrine surgery clinical outcomes research. 
  
Research Program Building / Leadership  
None 
 
Research Demonstration Activities  
None 
 
Inventions, Patents, Copyrights  
None 
 
Technology Transfer Activities  
None 
 
SYSTEM INNOVATION AND QUALITY IMPROVEMENT ACTIVITIES  
System Innovation Focus  
My primary system innovation focus has centered around improving patient safety and quality.  As a 
physician champion of Enhanced Recovery after Surgery (ERAS), my goal was to coordinate and 
standardize patient discharge after thyroidectomy across multiple disciplines at Johns Hopkins Hospital.  
As the Site Director of Collaborative Endocrine Surgery Quality Improvement Program (CESQIP), my goal 
is to incorporate Johns Hopkins endocrine surgical outcomes within this national database to ultimately 
help us improve quality of care and outcomes for our patients.  
 
System Innovation and Quality Improvement efforts within JHMI: 
1/2015-1/2016 Physician Champion, Enhanced Recovery After Surgery (ERAS) Thyroid Clinical 
Pathway. surgeon representative to create a standard pathway for early and 
safe discharge after thyroid surgery 
10/2017 - present Physician Champion, Comprehensive Unit-based Safety Program (CUSP) in The 
Johns  
Hopkins Outpatient Center Operating Room (JHOC OR). Responsible for 
representing surgeons perspective as well as serving as a liaison to address any 
safety concerns and ensure safe care in the JHOC OR. 
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7/2020 – present Site Director, Collaborative Endocrine Surgery Quality Improvement Program 
(CESQIP). This is a national quality improvement registry founded by members 
of the American Association of Endocrine Surgeons  that collects data on 
endocrine surgical procedures.  
 
System Innovation and Quality Improvement efforts outside of JHMI: 
None 
 
System Innovation and Quality Improvement Program Building/Leadership: 
None 
 
ORGANIZATIONAL ACTIVITIES  
 
Institutional Administrative Appointments  
2017- present Member, Compensation Committee Department of Surgery 
2017- present  Physician Champion, JHOC CUSP Committee 
2018- present Member, Department of Surgery Employee Recognition Committee 
2020- present Member, Johns Hopkins University School of Medicine Admissions Committee 
2021- present Co-Director, Women in Surgery at Hopkins (WISH) 
2021- present Co-Director, Johns Hopkins Thyroid Tumor Center 
 
Editorial Activities   
None 
 
Editorial Board appointments 
2020-present Member, Editorial Board, Frontiers in Endocrinology 
2020-present Member, Editorial Board, Thyroid 
 
Journal peer review activities    
2016-present Thyroid 
2016-present World Journal of Surgery 
2017-present Surgery 
2018-present American Journal of Surgery 
2018-present British Medical Journal Case Reports 
2018-present Journal of Surgical Research 
2019-present BMC Cancer Journal 
 
Other peer review activities  
None 
 
Advisory Committees, Review Groups/Study Sections 
2017 – present  Invited Member, ECOG-ACRIN National Surgery Committee 
2019 – present Selected Early Career NIH Study Section Program Member (Invitations to be ad 
hoc NIH Study section member for NIH grants) 
6/2019 Invited NCI Study Section Member, Clinical Oncology Study Section (CONC) 
 Denver, CO, June 17-18, 2019. 
2/2021 Invited Member, NIA Research Centers Collaborative Network Inclusion of Older 




Professional Societies  
2010-present American Association of Endocrine Surgeons 
  2010-present Member 
  2017-present  Collaborative Endocrine Surgery Quality Improvement Program (CESQIP) 
Committee 
  2017-present Fellowship Committee 
2013-present American Thyroid Association   
2013-present Member 
2019-present Trainees and Career Advancement Committee 
2020-present Research Evaluation Taskforce 
2015-present Association of Women Surgeons  
2015-present Member 
2019-present Institutional membership committee 
2015-present Member, American Association of Clinical Endocrinologists  
2015-present Fellow, American College of Surgeons 
  2020-present Geriatric Surgery Verification Task Force 
2016-present Member, American Association of Academic Surgeons  
Member, Endocrine Society 
2018-present Member, Society of Asian Academic Surgeons 
  
Conference Organizer  
JHMI/Regional 
11/9/2018 Conference Co-Director Contemporary Surgical Management of Thyroid and Parathyroid 
Disease, The Johns Hopkins Hospital 
11/22/2019 Conference Co-Director Contemporary Surgical Management of Thyroid and Parathyroid 









4/9/2019 Session Chair, American Association of Endocrine Surgeons, Annual Meeting, Los 
Angeles, CA 
9/26/2019  Session Chair, Society of Asian Academic Surgeons, Annual Meeting, Boston, MA 
 
International 
8/13/2019 Session Chair, International Association of Endocrine Surgeons Meeting, Annual 









Awards, Honors  
 
2010  American Association of Endocrine Surgeons, Best Clinical Poster Award  
2010  Charles A. Hufnagel Award for Excellence in Basic Science Research,  
2011  Marie J. Simonian Award for Excellence in Clinical Research  
2012  String of Pearls Teaching Award Nominee 
2013  American Thyroid Association Training Grant 
2018     Selected as a Johns Hopkins School of Medicine Interprofessional Collaborative 
             Practice Physician Exemplar (faculty representing the field of medicine in healthcare as 
a physician 
          role model for pre and post licensure learners in nursing, medicine, pharmacy and public health; 
23 
          institutionally selected) 
2019     Selected as a Johns Hopkins School of Medicine Interprofessional Collaborative 
             Practice Physician Exemplar (faculty representing the field of medicine in healthcare as 
a physician 
             role model for pre and post licensure learners in nursing, medicine, pharmacy and public health; 
23 
             institutionally selected) 
2019     Invited abstract judge for the 2020 Medical Student Research Symposium 
2020     Selected as a Johns Hopkins School of Medicine Interprofessional Collaborative 
             Practice Physician Exemplar (faculty representing the field of medicine in healthcare as 
a physician 
             role model for pre and post licensure learners in nursing, medicine, pharmacy and public health; 
23 





12/2014 Speaker, Surgical Grand Rounds, Sibley Memorial Hospital “Thyroid Surgery in the Era of 
Molecular Markers,” Washington DC  
11/2015 Speaker, Center of Older Americans Independence Center “Thyroid Gland and Frailty” 
Baltimore, MD 
11/2016 Speaker, Contemporary Surgical Management of Thyroid and Parathyroid Disease 
   “Medullary Thyroid Cancer”, Baltimore, MD 
11/2018 Speaker, Contemporary Surgical Management of Thyroid and Parathyroid Disease 
   “Medullary Thyroid Cancer” Baltimore, MD 
11/2019 Speaker, Contemporary Surgical Management of Thyroid and Parathyroid Disease 
   “Medullary Thyroid Cancer” 
9/20/2019 Speaker, The Johns Hopkins Inaugural Contemporary Issues in Adrenal Disorders CME 
   “Surgical Approaches to Adrenal Disease” Baltimore, MD 
1/18/2020 Speaker, The American College of Surgeons Metropolitan DC Chapter 
   “Endocrine Surgery Absite Review” Fairfax, VA 
4/2/2020 Speaker, Surgical Grand Rounds, The Johns Hopkins Hospital “Ageism and Thyroid 
Surgery” 
   Baltimore, MD 
















OTHER PROFESSIONAL ACCOMPLISHMENTS 
 
Posters 
4/10 Aarti Mathur, Mahadev Rao, Yuwei Zhang, Mary Zhang, Clint D. Kemp, Robert T. Ripley, 
Julie Hong, Fang Liu, Itzhak Avital, David S. Schrump.  “Cigarette smoke induces 
expression of the putative stem cell marker ABCG2 in cultured esophageal 
adenocarcinoma cells.”  American Association for Cancer Research Annual Meeting, 
Washington, D.C. 
 
4/10 Aarti Mathur, Clinton D. Kemp, Utpal Dutta, Smita Baid, Alejandro Ayala, Richard E Chang, Seth 
Steinberg, Eileen Lange RN, James F. Pingpank, H. Richard Alexander, W. Marston Linehan, Peter 
A. Pinto, Giao Phan, Marybeth Hughes, Steven K. Libutti, Constantine Stratakis, Electron 
Kebebew.  “Adrenal Venous Sampling in Primary Hyperaldosteronism: Standardizing a Gold 
Standard.”  American Association of Endocrine Surgeons Annual Meeting, Pittsburgh, PA 
 
10/16 Mathur A, Nagarajan N, Kahan S, Schneider EB, Zeiger MA. “Association of parathyroid 
hormone level with post-thyroidectomy hypocalcemia: A systematic-review.” American Thyroid 
Association Annual Meeting, Denver, Colorado. 
 
4/17 Sahli Z, Najafian A, Kahan S, Schneider EB, Zeiger MA, Mathur A. “One-hour postoperative 
parathyroid hormone levels do not reliably predict hypocalcemia after thyroidectomy.” American 
Association of Endocrine Surgeons Annual Meeting, Orlando, FL. 
 
10/17 Sahli Z, Canner JK, Najjar O, Schneider EB, Prescott JD, Russell JO, Tufano RP, Zeiger MA, 
Mathur A. “The Association between Age and Patient-reported Changes in Voice and 
Swallowing after Thyroidectomy.” American Thyroid Association Annual Meeting, Victoria, BC, 
Canada. 
 
10/18 Murad F, Canner JK, Haut E, Prescott JD, Segev DL, Zeiger MA, Mathur A. “The 
Epidemiology of Thyroid Cancer in Older Adults.” American Thyroid Association Annual 




8/19 Shank JB, Alkahili E, Canner JK, Hamrahian A, Munir M, Salvatori R, Prescott JD, Mathur A. 
“Unilateral adrenalectomy as initial management of Cushing’s syndrome secondary to bilateral 
macronodular hyperplasia.” International Association of Endocrine Surgeons Meeting, Krakow 
Poland. 
 
10/19 Sutton W, Canner JK, Segev DL, Zeiger MA, Mathur A. “Differentiated thyroid cancer in older 
adults: Does a treatment disparity still exist?” American Thyroid Association Annual Meeting, 
Chicago, IL.  
 
 
Oral/Podium Presentations  
 
4/2010 Aarti Mathur, Julie Weng , Willieford Moses , Seth Steinberg, Quan-Yang Duh, Orlo H. Clark, Electron Kebebew.  
“A prospective trial evaluating the accuracy of using combined clinical factors and candidate 
diagnostic markers to refine the accuracy of thyroid fine needle aspiration biopsy.”  American 
Association of Endocrine Surgeons Annual Meeting, Pittsburgh, PA. 
 
4/14 Aarti Mathur, Alireza Najafian, Eric B. Schneider, Martha A. Zeiger, Matthew T. Olson. 
“Malignancy risk and reproducibility associated with atypia of undetermined significance on 
thyroid cytology.”  American Association of Endocrine Surgeons Annual Meeting, Boston, MA.  
 
4/15 Noureldine SI, Najafian A, Aragon Han P, Olson MT, Genther DJ, Schneider EB, Prescott JD, 
Agrawal N, Mathur A, Zeiger MA, Tufano RP. “Evaluation of the effect of diagnostic molecular 
testing on the surgical decision-making process for patients with thyroid nodules”. American 
Association of Endocrine Surgeons Annual Meeting, Nashville, TN. [Dr. Noureldine gave the 
talk] 
 
4/17  Karipineni F, Sahli Z, Somervell H, Mathur A, Prescott JD, Tufano RP, Zeiger MA. “Are 
preoperative sestamibi scans useful for identifying ectopic parathyroid glands in patients with 
expected multigland parathyroid disease?” American Association of Endocrine Surgeons Annual 
Meeting, Orlando, FL. [Dr. Karipineni gave the talk] 
 
10/18 Sahli ZT, Ansari G, Gurakar M, Canner JK, Segev D, Zeiger MA, Mathur A. “Thyroidectomy in 
older adults: an ACS-NSQIP study of outcomes.” Association of Academic Surgery Annual 
Meeting, Jacksonville, FL [Dr. Sahli gave the talk] 
 
5/18 Sahli ZT, Karipineni F, Hang, Canner JK, Mathur A, Prescott JD, Sheth S, Ali SZ, Zeiger MA. 
“The Association between Ultrasonography TIRADS Classification System and Surgical 
Pathology Among Indeterminate Thyroid Nodules.” American Association of Endocrine 
Surgeons Annual Meeting, Durham, NC 
 
4/20 Sutton W, Genberg B, Prescott JD, Segev DL, Zeiger MA, Bandeen-Roche K, Mathur A. 
Understanding Surgical Decision-Making in Older Adults with differentiated thyroid cancer: A 
discrete choice experiment.  
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 American Association of Endocrine Surgeons Annual Meeting, Birmingham, AL. Meeting 
cancelled 
 
2/21 Sutton W, Ahn JB, Prescott JD, Zeiger MA, Segev DL, McAdams-DeMarco M, Mathur A. 
Association between treatment of secondary hyperparathyroidism and post-transplant outcomes. 
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FIELD OF STUDY 
 
University of Texas, Austin, TX B.A. 08/1996 05/2000 Biochemistry 
University of Texas Medical Branch, 
Galveston, TX 
M.D. 08/2000 05/2004 Medicine 
Georgetown University Hospital, 
Washington, DC 
 07/2004 06/2005 Intern, General 
Surgery 
Georgetown University Hospital, 
Washington, DC 
 07/2005 06/2007 Residency, General 
Surgery 
The National Cancer Institute, 
Bethesda, MD 
    07/2007 06/2011 Research & Clinical 
Fellow Surgical 
Oncology 
Georgetown University Hospital, 
Washington DC 
 07/2011 06/2013 Residency, General 
Surgery 
The Johns Hopkins Hospital 
Baltimore, MD 
 07/2013 06/2014 Fellowship, Endocrine 
Surgery 
The Johns Hopkins Bloomberg School 
of Public Health 




A. Personal Statement 
I am a board-certified general surgeon and a fellowship-trained endocrine surgeon with 
multiple years of research experience applying for the Atterbury Family Foundation Discovery 
Grant.  My primary clinical and research interests are focused on improving the care and 
outcomes of older patients with thyroid cancer. My motivation to better understand the 
decision-making process in managing endocrine surgical diseases in older adults stems from my 
interactions with patients and their treatment failures.  I am currently funded by an NIA K23 
Mentored Career Development Award to study the association between frailty with post-
operative changes in voice, swallowing, and quality of life following thyroidectomy in older 
adults.  Over the past 3 years, I have published multiple manuscripts examining how age and 
frailty affect post-surgical outcomes in older adults (Contribution 1).  I have also started to 
understand the decision-making process in managing well differentiated thyroid cancer in older 
adults (Contribution 2).  In addition, I have also completed advanced coursework in Clinical 
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Investigation for the Johns Hopkins Bloomberg School of Public Health that will lead to a PhD 
this year.  
Although I have previously studied decision making from the eyes of surgeons, this proposal will 
focus on patient centered decision making with the goal of improving risk stratification and 
prognostication to develop a personalized approach to treatment of older patients with thyroid 
cancer.  The ultimate goal of this work is to generate preliminary data for submission on an NIH 




B. Positions and Honors 
Positions and Employment 
2004-2005  Internship, Department of General Surgery, Georgetown University, 
Washington, DC   
2005-2007  Residency, Department of General Surgery, Georgetown University, 
Washington, DC  
2007-2011  Fellowship, National Cancer Institute/Surgical Oncology National Institute 
of Health 
     Bethesda, MD 
2011-2013  Residency, Department of General Surgery, Georgetown University, 
Washington, DC 
2013-2014  Fellowship, Endocrine Surgery, The Johns Hopkins University, Baltimore, 
MD  
2014-2020  Assistant Professor, Department of Surgery, The Johns Hopkins University 
School of Medicine, 
     Baltimore, MD 
2020-present Associate Professor, Department of Surgery, The Johns Hopkins University 
School of Medicine,  
     Baltimore, MD 
 
Other Experience and Professional Memberships 
2007-   District of Columbia Medical License 
2010-   Member, American Association of Endocrine Surgeons 
2013-   Member, American College of Surgeons 
2014-   State of Maryland Medical License 
2014-   Board Certified, American Board of Surgery 
2014-    Member, American Thyroid Association 
2014-   Member, Association of Women Surgeons 
2017-   Fellow, American College of Surgeons 
 
Honors 
2010    American Association of Endocrine Surgeons Poster Competition Award 
2010    Charles A. Hufnagel Award for Excellence in Basic Science Research 
2011    Marie J. Simonian Award for Excellence in Clinical Research  
2012    String of Pearls Teaching Award Nominee 
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2013    American Thyroid Association Training Grant 
2015   The Johns Hopkins Department of Surgery Rothman Research Award 
2016   The Johns Hopkins Clinician Scientist Award 
 
 
C. Contributions to Science 
 
1. Effects of Aging on Thyroid Cancer Diagnosis and Management 
One of my primary research interests is endocrine surgical outcomes in older adults, 
specifically thyroid cancer.  I have focused on understanding how age and frailty affect 
outcomes after thyroidectomy. We have demonstrated that older adults can have self-
reported changes in voice and swallowing after thyroidectomy.  Additionally, older adults 
can have worse clinical outcomes after thyroidectomy.   
 
a. Sutton W, Canner JK, Rooper LM, Prescott JD, Zeiger MA, Mathur A. Is patient age 
associated with risk of malignancy in a ³4cm cytologically benign thyroid nodule? The 
Am J of Surg. 2020, June 2. PMID: 32532458; NIHMS ID: NIHMS1603450 
b. Sahli ZT, Canner JK, Najjar O, Schneider EB, Prescott JD, Russell JO, Tufano RP, 
Zeiger MA, Mathur A. Association between age and patient-reported changes in voice 
and swallowing after thyroidectomy. Laryngoscope. 2019; 129(2):519-524.  PMCID: 
PMC6344315 
c. Sahli ZT, Zhou S, Najjar O, Onasanya O, Segev DL, Massie A, Zeiger MA, Mathur A. 
Octogenarians have worse clinical outcomes after thyroidectomy. Am J Surg. 2018; 
216(6):1171-1176. PMCID: PMC6197934 
d. Sahli ZT, Ansari G, Gurakar M, Canner JK, Segev DL, Zeiger MA, Mathur A. 
Thyroidectomy in older adults: an ACS-NSQIP study of outcomes. J Surgical Research. 
2018; 229:20-27. PMCID: PMC6042653 
 
2. Treatment Variation and Surgical Decision-Making in Older Adults with Thyroid Cancer 
Another area of focus as a surgeon has been understanding treatment variations for thyroid 
cancer and decision making in older adults.  We were one of the first groups in the country to 
perform a discrete choice experiment to understand surgical decision making in older adults 
with differentiated thyroid cancer.  We have also shown that significant treatment variations exist 
in managing older adults with thyroid cancer.   
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3.  Improving outcomes in patients with hyperparathyroidism. 
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Another area of research focus is understanding how to optimize diagnostic and surgical 
outcomes for patients with hyperparathyroidism.  We have studied optimizing parathyroid 
hormone levels in addition to sestamibi imaging to achieve better ultimate outcomes for 
patients.   
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4. Thyroid gland and molecular testing to identify thyroid cancer 
My focus on the thyroid gland involved refining the accuracy of fine-needle aspiration biopsy 
for an indeterminate thyroid nodule using molecular markers or second review of cytology.  To 
support the use of molecular markers, we discovered an increasing prevalence of BRAF 
mutation over time in papillary thyroid carcinomas. 
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5. Gene therapy and stem cell markers 
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My initial publications involved translational basic science to incorporate gene therapy and 
stem cell markers in treating various malignancies.  I was initially involved in studying the role 
of adoptive cell transfer and the timing of surgical treatment in metastatic melanoma.  After 
treating patients with human and mouse T-cells targeted to specific melanoma antigens, we 
observed tumor responses in patients with metastatic melanoma. We then studied the role of 
metastasectomy and found that it could prolong survival in a select group of patients. These 
concepts were then expanded to metastatic pancreatic cancer, lung, and esophageal cancer. 
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